<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="es"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d1 20130915//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Rev Esp Quimioter</journal-id><journal-id journal-id-type="iso-abbrev">Rev Esp Quimioter</journal-id><journal-id journal-id-type="publisher-id">Sociedad Espa&#x000f1;ola de Quimioterapia</journal-id><journal-title-group><journal-title>Revista Espa&#x000f1;ola de Quimioterapia</journal-title></journal-title-group><issn pub-type="ppub">0214-3429</issn><issn pub-type="epub">1988-9518</issn><publisher><publisher-name>Sociedad Espa&#x000f1;ola de Quimioterapia</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7528416</article-id><article-id pub-id-type="pmid">32683837</article-id><article-id pub-id-type="publisher-id">revespquimioter-33-313</article-id><article-id pub-id-type="doi">10.37201/req/064.2020</article-id><article-categories><subj-group subj-group-type="heading"><subject>Revisi&#x000f3;n Exploratoria</subject></subj-group></article-categories><title-group><article-title>Revisi&#x000f3;n exploratoria sobre series de casos de coronavirus (SARS-CoV, MERS-CoV y SARS-CoV-2) y sus resultados obst&#x000e9;tricos y neonatales</article-title><trans-title-group xml:lang="en"><trans-title>Scoping review of coronavirus case series (SARS-CoV, MERS-CoV and SARS-CoV-2) and their obstetric and neonatal results</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rodr&#x000ed;guez-Blanco</surname><given-names>Noelia</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Vegara-Lopez</surname><given-names>Irene</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Aleo-Giner</surname><given-names>Loreto</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Tuells</surname><given-names>Jos&#x000e9;</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><aff id="aff1"><label>1</label>Servicio Obstetricia Ginecolog&#x000ed;a. Hospital Universitario del Vinalop&#x000f3;, Elche (Espa&#x000f1;a)</aff><aff id="aff2"><label>2</label>Departamento de Enfermer&#x000ed;a. Universidad Cardenal Herrera-CEU, CEU Universities, Elche (Espa&#x000f1;a)</aff><aff id="aff3"><label>3</label>Servicio de Investigaci&#x000f3;n y Docencia M&#x000e9;dica. Hospital Universitario del Vinalop&#x000f3;, Elche (Espa&#x000f1;a)</aff><aff id="aff4"><label>4</label>Departamento de Enfermer&#x000ed;a Comunitaria, Medicina Preventiva y Salud P&#x000fa;blica e Historia de la Ciencia. Universidad de Alicante. Alicante (Espa&#x000f1;a)</aff></contrib-group><author-notes><corresp id="cor1">Correspondencia: Noelia Rodriguez-Blanco Departamento de Ciencias Biom&#x000e9;dicas. Universidad CEU Cardenal Herrera. Plaza Reyes Cat&#x000f3;licos n&#x000aa;19. 03204. Elche (Alicante) E-mail: <email>noelia.rodriguez@uchceu.es</email> Tel&#x000e9;fono: 965426486 FAX: 965426486</corresp></author-notes><pub-date pub-type="epub"><day>20</day><month>7</month><year>2020</year></pub-date><pub-date pub-type="ppub"><year>2020</year></pub-date><volume>33</volume><issue>5</issue><fpage>313</fpage><lpage>326</lpage><history><date date-type="received"><day>18</day><month>6</month><year>2020</year></date><date date-type="rev-recd"><day>01</day><month>7</month><year>2020</year></date><date date-type="rev-recd"><day>11</day><month>7</month><year>2020</year></date><date date-type="accepted"><day>15</day><month>7</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9;The Author 2020</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/"><license-p>This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>).</license-p></license></permissions><abstract><title>RESUMEN</title><sec id="st1"><title>Antecedentes</title><p>La aparici&#x000f3;n de nuevas enfermedades infecciosas, como el COVID-19, supone un reto en el seguimiento de la gestaci&#x000f3;n y la prevenci&#x000f3;n de complicaciones obst&#x000e9;tricas y neonatales. La revisi&#x000f3;n exploratoria tiene el objetivo de revisar la informaci&#x000f3;n disponible en mujeres embarazadas infectadas por los coronavirus MERS-CoV, SARS-CoV, SARS-CoV-2 para evaluar las similitudes y diferencias en las caracter&#x000ed;sticas cl&#x000ed;nicas de las madres y los resultados neonatales.</p></sec><sec id="st2"><title>M&#x000e9;todos</title><p>Realizamos una b&#x000fa;squeda bibliogr&#x000e1;fica (revisi&#x000f3;n exploratoria) acorde a las pautas de PRISMA entre marzo y abril del 2020 en las bases de datos de MEDLINE, SciELO, y CUIDEN y el Centro de Informaci&#x000f3;n sobre el COVID-19 de Elsevier.</p></sec><sec id="st3"><title>Resultados</title><p>Analizamos 20 art&#x000ed;culos con un total de 102 casos: 9 de MERS-CoV, 14 de SARS-CoV y 79 de SARS-CoV-2. La fiebre (75,5%) y la neumon&#x000ed;a (73,5%) resultaron ser los s&#x000ed;ntomas m&#x000e1;s frecuentes en las gestantes infectadas. Las complicaciones obst&#x000e9;tricas m&#x000e1;s frecuentes fueron la amenaza de parto prematuro (23,5%) y la ces&#x000e1;rea (74,5%). No se document&#x000f3; ninguna transmisi&#x000f3;n vertical en los neonatos.</p></sec><sec id="st4"><title>Conclusiones</title><p>Los tres coronavirus producen una neumon&#x000ed;a con sintomatolog&#x000ed;a muy similar, resultando m&#x000e1;s leve en el caso de SARS-CoV-2. A pesar de las complicaciones obst&#x000e9;tricas documentadas, los resultados neonatales son favorables en su mayor&#x000ed;a. Es preciso aumentar el conocimiento para mejorar y prevenir las complicaciones obst&#x000e9;tricas y neonatales de estas infecciones en mujeres embarazadas.</p></sec></abstract><trans-abstract xml:lang="en"><title>ABSTRACT</title><sec id="st5"><title>Background</title><p>The appearance of new infectious diseases, such as COVID-19, poses a challenge in monitoring pregnancy and preventing obstetric and neonatal complications. A scoping review has the objective to review the information available in pregnant women infected with the MERS-CoV, SARSCoV, SARS-CoV-2 coronaviruses to assess the similarities in terms of and differences in the clinical characteristics of the mothers and neonatal outcomes.</p></sec><sec id="st6"><title>Methods</title><p>We carried out a bibliographic search (scoping review) according to the PRISMA guidelines between March and April 2020 in the MEDLINE, SciELO, and CUIDEN databases and the Elsevier COVID-19 Information Center.</p></sec><sec id="st7"><title>Results</title><p>We analyzed 20 articles with a total of 102 cases.9 of MERS-CoV, 14 of SARS-CoV and 79 of SARS-CoV-2. Fever (75.5%) and pneumonia (73.5%) were the most frequent symptoms in infected pregnant women. The most frequent obstetric complications were the threat of premature delivery (23.5%) and caesarean section (74.5%). No vertical transmission was documented in any of the infants.</p></sec><sec id="st8"><title>Conclusions</title><p>All three coronaviruses produce pneumonia with very similar symptoms, being milder in the case of SARSCoV2. Despite documented obstetric complications, neonatal outcomes are mostly favorable. Increased knowledge is needed to improve and prevent obstetric and neonatal complications from these infections in pregnant women.</p></sec></trans-abstract><kwd-group><title>Palabras clave</title><kwd>Coronavirus</kwd><kwd>MERS-CoV</kwd><kwd>SARS-CoV</kwd><kwd>SARS-CoV-2</kwd><kwd>S&#x000ed;ndrome Respiratorio Agudo Severo (SARS)</kwd><kwd>S&#x000ed;ndrome Respiratorio de Oriente Medio (MERS)</kwd><kwd>COVID-19</kwd><kwd>Mujeres Embarazadas</kwd></kwd-group><kwd-group xml:lang="en"><title>Keywords</title><kwd>Coronavirus</kwd><kwd>MERS-CoV</kwd><kwd>SARS-CoV</kwd><kwd>SARS-CoV-2</kwd><kwd>Severe Acute Respiratory Syndrome (SARS)</kwd><kwd>Middle East Respiratory Syndrome (MERS)</kwd><kwd>COVID-19</kwd><kwd>Pregnant Women</kwd></kwd-group></article-meta></front><body><sec id="S1"><title>INTRODUCCI&#x000d3;N</title><p>A lo largo de los &#x000fa;ltimos veinte a&#x000f1;os, se ha producido el aumento y una r&#x000e1;pida expansi&#x000f3;n de ciertas enfermedades infecciosas debido a la extraordinaria conectividad que define a nuestra civilizaci&#x000f3;n global [<xref rid="ref1" ref-type="bibr">1</xref>]. Algunas de ellas, el S&#x000ed;ndrome Respiratorio Agudo Severo (SARS) (2003), la gripe H1N1 (2009), el &#x000c9;bola (2014) o el Zika (2015) afectan especialmente a las mujeres gestantes, ya que pueden producir una p&#x000e9;rdida del embarazo o da&#x000f1;os cong&#x000e9;nitos graves [<xref rid="ref2" ref-type="bibr">2</xref>,<xref rid="ref3" ref-type="bibr">3</xref>].</p><p>En diciembre del 2019, emergi&#x000f3; un agrupamiento de casos de neumon&#x000ed;a en la ciudad de Wuhan (provincia de Hubei, China), con una exposici&#x000f3;n com&#x000fa;n en un mercado que fue cerrado el d&#x000ed;a 1 de enero de 2020. Una semana despu&#x000e9;s se identific&#x000f3; como agente causal del brote un virus de la familia <italic>Coronaviridae</italic> que posteriormente fue denominado SARS-CoV-2. La enfermedad causada por este nuevo virus ha sido denominada por consenso internacional COVID-19, cuyo primer caso en Espa&#x000f1;a se produjo en La Gomera el 31 de enero. Posteriormente, el 11 de marzo, la Organizaci&#x000f3;n Mundial de la Salud declar&#x000f3; el estado de pandemia [<xref rid="ref4" ref-type="bibr">4</xref>-<xref rid="ref7" ref-type="bibr">7</xref>].</p><p>De los siete tipos de coronavirus que infectan a los humanos, tres de ellos, MERS-CoV, SARS-CoV, SARS-CoV-2, pueden generar un cuadro de s&#x000ed;ndrome respiratorio severo. El primero en aparecer fue el SARS-CoV identificado en China (2003) que se extendi&#x000f3; por 26 pa&#x000ed;ses y ocasion&#x000f3; cerca de 8000 casos. El segundo, conocido como MERS-CoV y que produc&#x000ed;a el S&#x000ed;ndrome Respiratorio del Medio Oriente (MERS) se identific&#x000f3; en Arabia Saudita en 2012 produciendo 2500 casos [<xref rid="ref6" ref-type="bibr">6</xref>]. Finalmente, el SARS-CoV-2 es el responsable de la actual pandemia en todo el mundo [<xref rid="ref8" ref-type="bibr">8</xref>].</p><p>Las mujeres embarazadas constituyen un grupo de especial riesgo y vulnerabilidad para las enfermedades de origen infeccioso [<xref rid="ref9" ref-type="bibr">9</xref>], debido a tres factores: su mayor compromiso cardio-respiratorio al avanzar la edad gestacional (sobre todo en el tercer trimestre) [<xref rid="ref10" ref-type="bibr">10</xref>], la inmunosupresi&#x000f3;n secundaria a la gestaci&#x000f3;n [<xref rid="ref11" ref-type="bibr">11</xref>], y las limitaciones en los tratamientos por el posible da&#x000f1;o al feto en cada trimestre de embarazo) [<xref rid="ref12" ref-type="bibr">12</xref>].</p><p>Hasta la fecha el virus respiratorio m&#x000e1;s com&#x000fa;n que ha afectado a las mujeres embarazadas es el virus de la gripe estacional [<xref rid="ref13" ref-type="bibr">13</xref>,<xref rid="ref14" ref-type="bibr">14</xref>] generando mayor morbilidad y muerte durante los periodos epid&#x000e9;micos [<xref rid="ref10" ref-type="bibr">10</xref>]. Este incremento de las complicaciones en la salud de las mujeres embarazadas, tambi&#x000e9;n se ha observado con los coronavirus que produjeron el SARS y el MERS [<xref rid="ref15" ref-type="bibr">15</xref>]. En el estudio realizado por Lam et. al.[<xref rid="ref16" ref-type="bibr">16</xref>] las mujeres embarazadas con SARS-CoV experimentaron un peor curso cl&#x000ed;nico en comparaci&#x000f3;n con las mujeres no embarazadas, presentando insuficiencia renal y coagulopat&#x000ed;a intravascular diseminada, adem&#x000e1;s de mayores ingresos en la Unidad de Cuidados Intensivos (UCI). Tambi&#x000e9;n se observ&#x000f3; que si la tasa de mortalidad tras infecci&#x000f3;n por SARS-CoV se incrementaba un 10% en la poblaci&#x000f3;n general, en las mujeres embarazadas lo hac&#x000ed;a un 25% m&#x000e1;s [<xref rid="ref17" ref-type="bibr">17</xref>]. Tanto el SARS-CoV como el MERS-CoV han dado lugar a urgencias obst&#x000e9;tricas como la hemorragia preparto [<xref rid="ref18" ref-type="bibr">18</xref>], los partos prematuros [<xref rid="ref19" ref-type="bibr">19</xref>], el Desprendimiento Prematuro de Placenta Normalmente Inserta (DPPNI) [<xref rid="ref20" ref-type="bibr">20</xref>] e incluso el fallecimiento de la gestante [<xref rid="ref21" ref-type="bibr">21</xref>].</p><p>El SARS-CoV-2 est&#x000e1; infectando a mujeres embarazadas, lo que hace interesante realizar una revisi&#x000f3;n exploratoria para conocer en qu&#x000e9; manera las est&#x000e1; afectando y si existen similitudes o diferencias entre los casos cl&#x000ed;nicos y su evoluci&#x000f3;n obst&#x000e9;trica en las gestantes con diagn&#x000f3;stico confirmado de SARS-CoV, MERS-CoV y SARS-CoV-2, lo que constituye el objetivo de esta revisi&#x000f3;n.</p></sec><sec id="S2"><title>M&#x000c9;TODOS</title><p>Se ha llevado a cabo una revisi&#x000f3;n exploratoria [<xref rid="ref22" ref-type="bibr">22</xref>] con objeto de conocer en gestantes su sintomatolog&#x000ed;a general asociada a las infecciones por coronavirus, sus posibles complicaciones obst&#x000e9;tricas y sus resultados neonatales.</p><p>Para la elecci&#x000f3;n de documentos se establecieron los siguientes criterios de inclusi&#x000f3;n: art&#x000ed;culos originales sin importar el idioma en el que estuvieran escritos, texto completo, poblaci&#x000f3;n de mujeres embarazadas, casos &#x000fa;nicos o m&#x000fa;ltiples generados por la infecci&#x000f3;n viral durante el embarazo ocasionado por coronavirus (SARS-CoV, MERS-CoV y SARS-CoV-2) y calidad de la revista mediante factor de impacto publicado en la Web of Science (WoS), y excluyendo los que no cumpl&#x000ed;an los criterios inclusivos de mujeres embarazadas y coronavirus conjuntamente.</p><p>Se exploraron como fuentes de informaci&#x000f3;n las bases de datos: MEDLINE, SciELO y CUIDEN. Dada la situaci&#x000f3;n de pandemia de la COVID-19, se han puesto distintas fuentes bibliogr&#x000e1;ficas en acceso abierto sobre la literatura cient&#x000ed;fica disponible sobre coronavirus, por lo que seleccionamos el recurso de Elsevier para explorarlo a trav&#x000e9;s de su Web de Centro de Informaci&#x000f3;n sobre el COVID-19 accesible en <ext-link ext-link-type="uri" xlink:href="https://www.elsevier.com/connect/coronavirus-information-center">https://www.elsevier.com/connect/coronavirus-information-center</ext-link>.</p><p>Se estableci&#x000f3; una estrategia de b&#x000fa;squeda (<xref rid="T1" ref-type="table">tabla 1</xref>) utilizando combinaciones mediante operadores booleanos de OR y AND de los siguientes t&#x000e9;rminos controlados localizados en Desc y MeSH: &#x0201c;coronavirus&#x0201d;, &#x0201c;SARS-CoV&#x0201d;, &#x0201c;MERS-CoV&#x0201d;, &#x0201c;sindrome respiratorio agudo grave&#x0201d;, &#x0201c;severe acute respiratory syndrome&#x0201d; &#x0201c;sindrome respiratorio de Oriente Medio&#x0201d;, &#x0201c;middle east respiratory syndrome&#x0201d;, &#x0201c;embarazada&#x0201d; y &#x0201c;pregnant women&#x0201d; y &#x0201c;pregnant woman&#x0201d;. En formulario libre de las mencionadas fuentes bibliogr&#x000e1;ficas y en algunos casos en el campo de &#x0201c;t&#x000ed;tulo/abstract&#x0201d; de MEDLINE usamos libremente los t&#x000e9;rminos &#x0201c;COVID 19&#x0201d;, &#x0201c;COVID-19&#x0201d;, &#x0201c;COVID19&#x0201d;, &#x0201c;2019-nCov&#x0201d;, &#x0201c;2019nCov&#x0201d;, &#x0201c;SARS-CoV2&#x0201d;, &#x0201c;SARS-CoV-2&#x0201d;. La b&#x000fa;squeda bibliogr&#x000e1;fica comprendi&#x000f3; desde el a&#x000f1;o 2003 hasta la actualidad (abril 2020) y se realiz&#x000f3; entre el 2 de marzo y el 14 de abril del 2020.</p><table-wrap id="T1" orientation="portrait" position="float"><label>Tabla 1</label><caption><p>Estrategias de b&#x000fa;squeda empleadas</p></caption><table frame="border" rules="groups"><thead valign="top"><tr><th rowspan="1" colspan="1">Base de datos</th><th rowspan="1" colspan="1">Estrategia de b&#x000fa;squeda</th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1">MEDLINE</td><td rowspan="1" colspan="1">(((((((((((((((((((((((coronavirus[MeSH Terms]) OR coronavirus[Title/Abstract]) OR COVID 19[MeSH Terms]) OR COVID 19[Title/Abstract]) OR COVID-19[MeSH Terms]) OR COVID-19[Title/Abstract]) OR COVID19[MeSH Terms]) OR COVID19[Title/Abstract]) OR 2019-nCoV[MeSH Terms]) OR 2019-nCoV[Title/ Abstract]) OR 2019nCoV[MeSH Terms]) OR 2019nCoV[Title/Abstract]) OR SARS-CoV[MeSH Terms]) OR SARS-CoV[Title/Abstract]) OR SARS-CoV-2[MeSH Terms]) OR SARS-CoV-2[Title/Abstract]) OR SARS-CoV2[MeSH Terms]) OR SARS-CoV2[Title/Abstract]) OR MERS-CoV[MeSH Terms]) OR MERS-CoV[Title/ Abstract]) OR Severe acute respiratory sindrome[MeSH Terms]) OR Severe acute respiratory sindrome[Title/Abstract]) OR Middle East Respiratory Syndrome[MeSH Terms]) OR Middle East Respiratory Syndrome[Title/Abstract]</td></tr><tr><td rowspan="1" colspan="1">SciELO</td><td rowspan="1" colspan="1">CORONAVIRUS [Todos los indices] and EMBARAZADA [Todos los indices] <break/>CORONAVIRUS [Todos los indices] and PREGNANT [Todos los indices] <break/>COVID [Todos los indices] and PREGNANT [Todos los indices] <break/>COVID [Todos los indices] and EMBARAZADA [Todos los indices]</td></tr><tr><td rowspan="1" colspan="1">CUIDEN</td><td rowspan="1" colspan="1">CORONAVIRUS AND embarazada <break/>COVID 19 AND embarazada <break/>COVID 19 AND pregnant <break/>COVID 19 AND pregnant women <break/>COVID 19 AND pregnant woman</td></tr><tr><td rowspan="1" colspan="1">Elsevier</td><td rowspan="1" colspan="1">(&#x0201c;COVID-19&#x0201d; OR Coronavirus OR &#x0201c;Corona virus&#x0201d; OR &#x0201c;2019-nCoV&#x0201d; OR &#x0201c;SARS-CoV&#x0201d; OR &#x0201c;MERS-CoV&#x0201d; OR &#x0201c;Severe Acute Respiratory Syndrome&#x0201d; OR &#x0201c;Middle East Respiratory Syndrome&#x0201d;) AND (PREGNANT WOMAN OR PREGNANT WOMEN)</td></tr></tbody></table></table-wrap><p>Posteriormente se seleccionaron y clasificaron los estudios, as&#x000ed; como sus variables bibliom&#x000e9;tricas, de contenido y de calidad. Para evaluar la calidad metodol&#x000f3;gica, elegimos la herramienta de evaluaci&#x000f3;n critica de JBI para series de casos como los utilizados en el trabajo de Murad et. al.[<xref rid="ref23" ref-type="bibr">23</xref>] en funci&#x000f3;n de los dominios de selecci&#x000f3;n, verificaci&#x000f3;n, causalidad e informes. Se utiliz&#x000f3; una plantilla para extraer los siguientes datos: autor, a&#x000f1;o de publicaci&#x000f3;n, pa&#x000ed;s, tipo de dise&#x000f1;o de los estudios, objetivo y poblaci&#x000f3;n. Los datos fueron extra&#x000ed;dos y volcados a la plantilla por dos investigadores del equipo. Se observ&#x000f3; una considerable heterogeneidad entre los estudios y factores como el sesgo de publicaci&#x000f3;n y el informe selectivo de los resultados que no pudieron explicarse. Para la comunicaci&#x000f3;n de resultados se siguieron las pautas de la Declaraci&#x000f3;n PRISMA [<xref rid="ref24" ref-type="bibr">24</xref>,<xref rid="ref25" ref-type="bibr">25</xref>].</p></sec><sec sec-type="results" id="S3"><title>RESULTADOS</title><p>Las fuentes bibliogr&#x000e1;ficas consultadas inicialmente arrojaron un total de 162 art&#x000ed;culos reducidos a 157 tras eliminar las referencias duplicadas. La lectura de t&#x000ed;tulo y resumen condujo a la exclusi&#x000f3;n de 87 art&#x000ed;culos porque no mencionaban conjuntamente a las mujeres embarazadas con coronavirus. De los 70 art&#x000ed;culos le&#x000ed;dos a texto completo, se seleccionaron 20 art&#x000ed;culos finales y se descart&#x000f3; el resto porque no cumpl&#x000ed;an con todos los criterios de inclusi&#x000f3;n, tal como se muestra en la <xref ref-type="fig" rid="F1">figura 1</xref> del PRISMA.</p><fig id="F1" orientation="portrait" position="float"><label>Figura 1</label><caption><p>Diagrama de flujo selecci&#x000f3;n tipo PRISMA revisi&#x000f3;n exploratoria</p></caption><graphic xlink:href="revespquimioter-33-313-g001"/></fig><p>La mayor&#x000ed;a de los 20 art&#x000ed;culos seleccionados proceden de China (9), seguidos de Corea (2), Arabia Saud&#x000ed; (2), EE. UU. (2), Jap&#x000f3;n (2), Honduras (1), Emiratos &#x000c1;rabes (1) y Jordania (1). Los dise&#x000f1;os de estudios son de tipo &#x0201c;series de casos&#x0201d; (12), &#x0201c;reporte de un caso&#x0201d; (7) y uno tipo &#x0201c;caso-control&#x0201d; (1). La poblaci&#x000f3;n elegida estaba compuesta de mujeres embarazadas, aunque hay cuatro que adem&#x000e1;s inclu&#x000ed;an a neonatos (<xref rid="T2" ref-type="table">tablas 2</xref> y <xref rid="T3" ref-type="table">3</xref>) [<xref rid="ref8" ref-type="bibr">8</xref>, <xref rid="ref12" ref-type="bibr">12</xref>, <xref rid="ref17" ref-type="bibr">17</xref>, <xref rid="ref18" ref-type="bibr">18</xref> , <xref rid="ref20" ref-type="bibr">20</xref>, <xref rid="ref21" ref-type="bibr">21</xref>, <xref rid="ref26" ref-type="bibr">26</xref>-<xref rid="ref39" ref-type="bibr">39</xref>].</p><table-wrap id="T2" orientation="portrait" position="float"><label>Tabla 2</label><caption><p>Estudios incluidos en la revisi&#x000f3;n sobre SARS-CoV-2.</p></caption><table frame="border" rules="groups"><thead valign="top"><tr><th align="center" rowspan="1" colspan="1">Autor</th><th align="center" rowspan="1" colspan="1">Pa&#x000ed;s <break/>A&#x000f1;o</th><th align="center" rowspan="1" colspan="1">Periodo de estudio</th><th align="center" rowspan="1" colspan="1">Dise&#x000f1;o de estudio</th><th align="center" rowspan="1" colspan="1">Objetivos</th><th align="center" rowspan="1" colspan="1">Poblaci&#x000f3;n</th></tr></thead><tbody valign="top"><tr><td align="center" rowspan="1" colspan="1">Chen [<xref rid="ref8" ref-type="bibr">8</xref>] et al.</td><td align="center" rowspan="1" colspan="1">China 2020</td><td align="center" rowspan="1" colspan="1">No reportado</td><td align="center" rowspan="1" colspan="1">Serie de casos</td><td align="center" rowspan="1" colspan="1">Describir los casos cl&#x000ed;nicos de beb&#x000e9;s nacidos de mujeres embarazadas con infecci&#x000f3;n por SARS-CoV-2.</td><td align="center" rowspan="1" colspan="1">Mujeres embarazadas y Neonatos</td></tr><tr><td align="center" rowspan="1" colspan="1">Zhu [<xref rid="ref26" ref-type="bibr">26</xref>] et al.</td><td align="center" rowspan="1" colspan="1">China 2020</td><td align="center" rowspan="1" colspan="1">20 enero 5 febrero</td><td align="center" rowspan="1" colspan="1">Serie de casos</td><td align="center" rowspan="1" colspan="1">Analizar retrospectivamente las caracter&#x000ed;sticas cl&#x000ed;nicas y los resultados de 10 neonatos de madres con infecci&#x000f3;n confirmada</td><td align="center" rowspan="1" colspan="1">Mujeres embarazadas y Neonatos</td></tr><tr><td align="center" rowspan="1" colspan="1">Chen <break/>[<xref rid="ref27" ref-type="bibr">27</xref>]et al.</td><td align="center" rowspan="1" colspan="1">China <break/>2020</td><td align="center" rowspan="1" colspan="1">20 enero 10 febrero</td><td align="center" rowspan="1" colspan="1">Serie de casos</td><td align="center" rowspan="1" colspan="1">Evaluar a las mujeres embarazadas infectadas por SARS-CoV-2 y proporcionar ayuda para la prevenci&#x000f3;n y el tratamiento cl&#x000ed;nico en China.</td><td align="center" rowspan="1" colspan="1">Mujeres embarazadas</td></tr><tr><td align="center" rowspan="1" colspan="1">Zambrano [<xref rid="ref28" ref-type="bibr">28</xref>] et al.</td><td align="center" rowspan="1" colspan="1">Honduras <break/>2020</td><td align="center" rowspan="1" colspan="1">19 marzo</td><td align="center" rowspan="1" colspan="1">Reporte de un caso</td><td align="center" rowspan="1" colspan="1">Informar de casos sobre mujeres embarazadas afectadas por el COVID-19 de Am&#x000e9;rica Central.</td><td align="center" rowspan="1" colspan="1">Mujeres embarazadas</td></tr><tr><td align="center" rowspan="1" colspan="1">Liu [<xref rid="ref29" ref-type="bibr">29</xref>] et al.</td><td align="center" rowspan="1" colspan="1">China 2020</td><td align="center" rowspan="1" colspan="1">8 diciembre 25 febrero</td><td align="center" rowspan="1" colspan="1">Serie de casos</td><td align="center" rowspan="1" colspan="1">Describir las caracter&#x000ed;sticas epidemiol&#x000f3;gicas, cl&#x000ed;nicas, del embarazo y los resultados perinatales de todas las pacientes embarazadas hospitalizadas diagnosticadas con COVID-19 en China</td><td align="center" rowspan="1" colspan="1">Mujeres embarazadas</td></tr><tr><td align="center" rowspan="1" colspan="1">Chen [<xref rid="ref30" ref-type="bibr">30</xref>] et al.</td><td align="center" rowspan="1" colspan="1">China 2020</td><td align="center" rowspan="1" colspan="1">20 31 enero</td><td align="center" rowspan="1" colspan="1">Serie de casos</td><td align="center" rowspan="1" colspan="1">Evaluar las caracter&#x000ed;sticas cl&#x000ed;nicas de COVID-19 en el embarazo y el potencial de transmisi&#x000f3;n vertical intrauterina.</td><td align="center" rowspan="1" colspan="1">Mujeres embarazadas</td></tr><tr><td align="center" rowspan="1" colspan="1">Liu [<xref rid="ref31" ref-type="bibr">31</xref>] et al.</td><td align="center" rowspan="1" colspan="1">China 2020</td><td align="center" rowspan="1" colspan="1">20 enero 10 febrero</td><td align="center" rowspan="1" colspan="1">Serie de casos</td><td align="center" rowspan="1" colspan="1">Describir las manifestaciones cl&#x000ed;nicas y las caracter&#x000ed;sticas de la neumon&#x000ed;a por SARS-CoV-2 en 15 mujeres embarazadas</td><td align="center" rowspan="1" colspan="1">Mujeres embarazadas</td></tr><tr><td align="center" rowspan="1" colspan="1">Wang [<xref rid="ref32" ref-type="bibr">32</xref>] et al.</td><td align="center" rowspan="1" colspan="1">China 2020</td><td align="center" rowspan="1" colspan="1">6 febrero</td><td align="center" rowspan="1" colspan="1">Reporte de un caso</td><td align="center" rowspan="1" colspan="1">Presentar un caso cl&#x000ed;nico de una mujer embarazada de 30 semanas con COVID-19 dando a luz a un beb&#x000e9; sano sin evidencia de enfermedad.</td><td align="center" rowspan="1" colspan="1">Mujeres embarazadas</td></tr><tr><td align="center" rowspan="1" colspan="1">Zhang [<xref rid="ref33" ref-type="bibr">33</xref>] et al.</td><td align="center" rowspan="1" colspan="1">China 2020</td><td align="center" rowspan="1" colspan="1">30 enero 17 febrero</td><td align="center" rowspan="1" colspan="1">Caso-Control</td><td align="center" rowspan="1" colspan="1">Estudiar el efecto de COVID-19 sobre los resultados del embarazo y el pron&#x000f3;stico neonatal en la provincia de Hubei.</td><td align="center" rowspan="1" colspan="1">Mujeres embarazadas</td></tr><tr><td align="center" rowspan="1" colspan="1">Yu [<xref rid="ref34" ref-type="bibr">34</xref>] et al.</td><td align="center" rowspan="1" colspan="1">China <break/>2020</td><td align="center" rowspan="1" colspan="1">1 enero 8 febrero</td><td align="center" rowspan="1" colspan="1">Serie de casos</td><td align="center" rowspan="1" colspan="1">Aclarar las caracter&#x000ed;sticas cl&#x000ed;nicas y los resultados obst&#x000e9;tricos y neonatales de pacientes embarazadas con SARS-CoV-2 en Wuhan, China.</td><td align="center" rowspan="1" colspan="1">Mujeres embarazadas</td></tr></tbody></table></table-wrap><table-wrap id="T3" orientation="portrait" position="float"><label>Tabla 3</label><caption><p>Estudios incluidos en la revisi&#x000f3;n sobre SARS-CoV y MERS-CoV.</p></caption><table frame="border" rules="groups"><thead valign="top"><tr><th align="center" rowspan="1" colspan="1">Autor</th><th align="center" rowspan="1" colspan="1">Pa&#x000ed;s <break/>A&#x000f1;o</th><th align="center" rowspan="1" colspan="1">Periodo de estudio</th><th align="center" rowspan="1" colspan="1">Dise&#x000f1;o de estudio</th><th align="center" rowspan="1" colspan="1">Objetivos</th><th align="center" rowspan="1" colspan="1">Poblaci&#x000f3;n</th></tr></thead><tbody valign="top"><tr><td align="center" rowspan="1" colspan="1">Malik [<xref rid="ref12" ref-type="bibr">12</xref>] et al.</td><td align="center" rowspan="1" colspan="1">Emiratos &#x000c1;rabes 2016</td><td align="center" rowspan="1" colspan="1">Noviembre 2013</td><td align="center" rowspan="1" colspan="1">Reporte de un caso</td><td align="center" rowspan="1" colspan="1">Presentaci&#x000f3;n de un caso cl&#x000ed;nico de una mujer embarazada con MERS-CoV que recibi&#x000f3; terapia con ribavirina-peginterfer&#x000f3;n-&#x003b1;</td><td align="center" rowspan="1" colspan="1">Mujeres embarazadas</td></tr><tr><td align="center" rowspan="1" colspan="1">Wong [<xref rid="ref17" ref-type="bibr">17</xref>] et al.</td><td align="center" rowspan="1" colspan="1">Jap&#x000f3;n <break/>2004</td><td align="center" rowspan="1" colspan="1">Febrero <break/>julio 2003</td><td align="center" rowspan="1" colspan="1">Serie de casos</td><td align="center" rowspan="1" colspan="1">Evaluar el embarazo y los resultados perinatales de mujeres embarazadas con s&#x000ed;ndrome respiratorio agudo severo en Hong Kong.</td><td align="center" rowspan="1" colspan="1">Mujeres embarazadas</td></tr><tr><td align="center" rowspan="1" colspan="1">Shek [<xref rid="ref18" ref-type="bibr">18</xref>] et al.</td><td align="center" rowspan="1" colspan="1">Jap&#x000f3;n <break/>2003</td><td align="center" rowspan="1" colspan="1">Marzo 2003</td><td align="center" rowspan="1" colspan="1">Serie de casos</td><td align="center" rowspan="1" colspan="1">Presentaci&#x000f3;n de 5 casos cl&#x000ed;nicos de beb&#x000e9;s nacidos vivos de mujeres embarazadas con SARS-CoV.</td><td align="center" rowspan="1" colspan="1">Mujeres embarazadas y Neonatos</td></tr><tr><td align="center" rowspan="1" colspan="1">Payne [<xref rid="ref20" ref-type="bibr">20</xref>] et al.</td><td align="center" rowspan="1" colspan="1">Jordania 2014</td><td align="center" rowspan="1" colspan="1">Abril 2012</td><td align="center" rowspan="1" colspan="1">Serie de casos</td><td align="center" rowspan="1" colspan="1">Investigar la epidemiologia entre los sobrevivientes de un brote de infecci&#x000f3;n por MERS-CoV en Jordania.</td><td align="center" rowspan="1" colspan="1">Mujeres embarazadas</td></tr><tr><td align="center" rowspan="1" colspan="1">Assiri [<xref rid="ref21" ref-type="bibr">21</xref>] <break/>et al.</td><td align="center" rowspan="1" colspan="1">Arabia Saudita 2016</td><td align="center" rowspan="1" colspan="1">Mayo 2014 <break/>julio 2015</td><td align="center" rowspan="1" colspan="1">Serie de casos</td><td align="center" rowspan="1" colspan="1">Describir los 5 casos de mujeres embarazadas de Arabia Saud&#x000ed; con infecci&#x000f3;n por MERS-CoV.</td><td align="center" rowspan="1" colspan="1">Mujeres embarazadas</td></tr><tr><td align="center" rowspan="1" colspan="1">Jeong [<xref rid="ref35" ref-type="bibr">35</xref>] et al.</td><td align="center" rowspan="1" colspan="1">Corea <break/>2017</td><td align="center" rowspan="1" colspan="1">Mayo <break/>2015</td><td align="center" rowspan="1" colspan="1">Reporte de un caso</td><td align="center" rowspan="1" colspan="1">Presentar un caso cl&#x000ed;nico de una embarazada de Corea con resultado positivo de la reacci&#x000f3;n en cadena de la polimerasa MERS-CoV</td><td align="center" rowspan="1" colspan="1">Mujeres embarazadas</td></tr><tr><td align="center" rowspan="1" colspan="1">Robertson [<xref rid="ref36" ref-type="bibr">36</xref>] et al.</td><td align="center" rowspan="1" colspan="1">EE. UU. <break/>2004</td><td align="center" rowspan="1" colspan="1">Febrero 2003</td><td align="center" rowspan="1" colspan="1">Reporte de un caso</td><td align="center" rowspan="1" colspan="1">Presentaci&#x000f3;n de un caso cl&#x000ed;nico confirmado por laboratorio de s&#x000ed;ndrome respiratorio agudo severo en una mujer embarazada.</td><td align="center" rowspan="1" colspan="1">Mujeres embarazadas</td></tr><tr><td align="center" rowspan="1" colspan="1">Park [<xref rid="ref37" ref-type="bibr">37</xref>] et al.</td><td align="center" rowspan="1" colspan="1">Corea <break/>2016</td><td align="center" rowspan="1" colspan="1">No reportado</td><td align="center" rowspan="1" colspan="1">Reporte de un caso</td><td align="center" rowspan="1" colspan="1">Presentaci&#x000f3;n de un caso cl&#x000ed;nico confirmado de MERS-CoV en la Rep&#x000fa;blica de Corea en una mujer en la semana gestacional 35 + 4.</td><td align="center" rowspan="1" colspan="1">Mujeres embarazadas</td></tr><tr><td align="center" rowspan="1" colspan="1">Stockman [<xref rid="ref38" ref-type="bibr">38</xref>] et al.</td><td align="center" rowspan="1" colspan="1">EE. UU. <break/>2004</td><td align="center" rowspan="1" colspan="1">Marzo 2003</td><td align="center" rowspan="1" colspan="1">Serie de casos</td><td align="center" rowspan="1" colspan="1">Presentaci&#x000f3;n del caso cl&#x000ed;nico de una mujer embarazada con afecci&#x000f3;n de SARS-CoV, y seguimiento 1 mes despu&#x000e9;s del nacimiento.</td><td align="center" rowspan="1" colspan="1">Mujeres embarazadas y Neonatos</td></tr><tr><td align="center" rowspan="1" colspan="1">Alserehi [<xref rid="ref39" ref-type="bibr">39</xref>] et al.</td><td align="center" rowspan="1" colspan="1">Arabia Saudita 2016</td><td align="center" rowspan="1" colspan="1">Abril 2012</td><td align="center" rowspan="1" colspan="1">Reporte de un caso</td><td align="center" rowspan="1" colspan="1">Presentaci&#x000f3;n de un caso cl&#x000ed;nico de la infecci&#x000f3;n por MERS-CoV en una mujer embarazada que adquiri&#x000f3; la infecci&#x000f3;n durante el &#x000fa;ltimo trimestre.</td><td align="center" rowspan="1" colspan="1">Mujeres embarazadas</td></tr></tbody></table></table-wrap><p>La muestra final recogi&#x000f3; casos de 102 gestantes, con una media de edad de 31,2 (DE&#x000b1;4,5) a&#x000f1;os; 79 gestantes correspond&#x000ed;an a casos de SARS-CoV-2; 14 gestantes correspond&#x000ed;an a casos de SARS-CoV y 9 gestantes a casos de MERS-CoV. La mayor&#x000ed;a de las infecciones se detectaron durante el segundo y tercer trimestre (32 semanas &#x000b1;10 semanas), exceptuando siete casos de SARS-CoV en los que la infecci&#x000f3;n se produjo durante el primer trimestre y que acabaron en un aborto espont&#x000e1;neo o voluntario. En la <xref rid="T4" ref-type="table">tabla 4</xref> se describen los datos comparativos sobre las tres enfermedades, resaltando la fiebre con un 89,5% (IC 95%: 82,696,3) y la neumon&#x000ed;a con un 81,5% (IC 95%: 72,7-90,2) los s&#x000ed;ntomas comunes de los tres coronavirus. Adem&#x000e1;s, se observ&#x000f3; que la Amenaza de Parto Prematuro (APP) con un 26,6% (IC 95%: 8,9-44,2) y la ces&#x000e1;rea con 85,4% (IC 95%:77,5-93,3) fueron las complicaciones obst&#x000e9;tricas m&#x000e1;s frecuentes.</p><table-wrap id="T4" orientation="portrait" position="float"><label>Tabla 4</label><caption><p>Comparativa entre SARS-CoV-2, SARS-CoV y MERS-CoV</p></caption><table frame="border" rules="groups"><thead valign="top"><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">SARS-CoV-2</th><th rowspan="1" colspan="1">SARS-CoV</th><th rowspan="1" colspan="1">MERS-CoV</th><th rowspan="1" colspan="1">TOTAL CORONAVIRUS</th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">n/N (%)<break/>N=79</th><th rowspan="1" colspan="1">n/N (%)<break/>N=14</th><th rowspan="1" colspan="1">n/N (%)<break/>N=9</th><th rowspan="1" colspan="1">n/N (%) [IC 95%]<break/>N=102</th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1">Edad</td><td rowspan="1" colspan="1">22 &#x02013; 41 (31&#x000b1;4)</td><td rowspan="1" colspan="1">2444 (31&#x000b1;6)</td><td rowspan="1" colspan="1">27 &#x02013; 39 (33&#x000b1;4)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">SA nacimiento</td><td rowspan="1" colspan="1">26 &#x02013; 41 (36&#x000b1;3)</td><td rowspan="1" colspan="1">3 &#x02013; 38 (19&#x000b1;15)</td><td rowspan="1" colspan="1">22 &#x02013; 38 (29&#x000b1;6)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Sintomatolog&#x000ed;a General Gestante</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Fiebre</td><td rowspan="1" colspan="1">55/64 (85,9%)</td><td rowspan="1" colspan="1">14/14 (100%)</td><td rowspan="1" colspan="1">8/8 (100%)</td><td rowspan="1" colspan="1">77/86 (89,5%) [82,6-96,3]</td></tr><tr><td rowspan="1" colspan="1">Mialgia</td><td rowspan="1" colspan="1">15/64 (23,4%)</td><td rowspan="1" colspan="1">14/14 (100%)</td><td rowspan="1" colspan="1">1/8 (12,5%)</td><td rowspan="1" colspan="1">30/86 (34,9%) [17,8-51,9]</td></tr><tr><td rowspan="1" colspan="1">Diarrea</td><td rowspan="1" colspan="1">7/79 (8,9%)</td><td rowspan="1" colspan="1">2/14 (14,3%)</td><td rowspan="1" colspan="1">0/8 (0,0%)</td><td rowspan="1" colspan="1">9/101 (8,9%) [0,0-27,5]</td></tr><tr><td rowspan="1" colspan="1">Tos</td><td rowspan="1" colspan="1">26/79 (32,9%)</td><td rowspan="1" colspan="1">11/14 (78,6%)</td><td rowspan="1" colspan="1">7/8 (87,5%)</td><td rowspan="1" colspan="1">45/101 (44,5%) [29,9-59,0]</td></tr><tr><td rowspan="1" colspan="1">Disnea</td><td rowspan="1" colspan="1">11/79 (13,9%)</td><td rowspan="1" colspan="1">6/14 (42,9%)</td><td rowspan="1" colspan="1">7/8 (87,5%)</td><td rowspan="1" colspan="1">24/101 (13,9%) [0,0-27,7]</td></tr><tr><td rowspan="1" colspan="1">Neumon&#x000ed;a</td><td rowspan="1" colspan="1">53/70 (75,7%)</td><td rowspan="1" colspan="1">14/14 (100%)</td><td rowspan="1" colspan="1">8/8 (100%)</td><td rowspan="1" colspan="1">75/92 (81,5%) [72,7-90,2]</td></tr><tr><td rowspan="1" colspan="1">UCI / VM</td><td rowspan="1" colspan="1">3/70 (4,3%)</td><td rowspan="1" colspan="1">14/14 (100%)</td><td rowspan="1" colspan="1">4/8 (50,0%)</td><td rowspan="1" colspan="1">21/92 (22,8%) [4,8-40,7]</td></tr><tr><td rowspan="1" colspan="1">Complicaciones Obst&#x000e9;tricas</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">HTA</td><td rowspan="1" colspan="1">6/74 (8,1%)</td><td rowspan="1" colspan="1">0/7 (0,0%)</td><td rowspan="1" colspan="1">1/9 (11,1%)</td><td rowspan="1" colspan="1">7/90 (7,6%) [0,0-27,2]</td></tr><tr><td rowspan="1" colspan="1">RPM</td><td rowspan="1" colspan="1">9/74 (12,1%)</td><td rowspan="1" colspan="1">1/7 (14,3%)</td><td rowspan="1" colspan="1">0/9 (0,0 %)</td><td rowspan="1" colspan="1">10/90 (23,4%) [0,0-49,6]</td></tr><tr><td rowspan="1" colspan="1">Coinfecciones</td><td rowspan="1" colspan="1">1/74 (1,3%)</td><td rowspan="1" colspan="1">4/7 (57,1%)</td><td rowspan="1" colspan="1">0/9 (0,0 %)</td><td rowspan="1" colspan="1">5/90 (8,9%) [0,0-33,9]</td></tr><tr><td rowspan="1" colspan="1">RPBF</td><td rowspan="1" colspan="1">14/74 (18,9%)</td><td rowspan="1" colspan="1">2/7 (28,5%)</td><td rowspan="1" colspan="1">0/9 (0,0 %)</td><td rowspan="1" colspan="1">16/90 (17,8%) [0,0-36,5]</td></tr><tr><td rowspan="1" colspan="1">APP</td><td rowspan="1" colspan="1">18/74 (24,3%)</td><td rowspan="1" colspan="1">5/7 (71,4%)</td><td rowspan="1" colspan="1">1/9 (11,1%)</td><td rowspan="1" colspan="1">24/90 (26,6%) [8,9-44,2]</td></tr><tr><td rowspan="1" colspan="1">Hemorragias</td><td rowspan="1" colspan="1">3/74 (4,0%)</td><td rowspan="1" colspan="1">4/7 (57,1%)</td><td rowspan="1" colspan="1">2/9 (22,2%)</td><td rowspan="1" colspan="1">9/90 (10,0%) [0,0-29,6]</td></tr><tr><td rowspan="1" colspan="1">RCIR</td><td rowspan="1" colspan="1">0/74 (0,0%)</td><td rowspan="1" colspan="1">2/7 (28,6%)</td><td rowspan="1" colspan="1">0/9 (0,0 %)</td><td rowspan="1" colspan="1">2/90 (2,2%) [79,1-85,3]</td></tr><tr><td rowspan="1" colspan="1">Muerte materna</td><td rowspan="1" colspan="1">0/79 (0,0%)</td><td rowspan="1" colspan="1">3/14 (21,4%)</td><td rowspan="1" colspan="1">3/9 (33,3%)</td><td rowspan="1" colspan="1">6/102 (5,8%) [0,0-26,4]</td></tr><tr><td rowspan="1" colspan="1">Fin de parto</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Parto vaginal</td><td rowspan="1" colspan="1">8/73 (11,0%)</td><td rowspan="1" colspan="1">1/7 (14,3%)</td><td rowspan="1" colspan="1">4/9 (44,4%)</td><td rowspan="1" colspan="1">13/89 (14,6%) [0,0-33,8]</td></tr><tr><td rowspan="1" colspan="1">Ces&#x000e1;rea</td><td rowspan="1" colspan="1">65/73 (89,0%)</td><td rowspan="1" colspan="1">6/7 (85,7%)</td><td rowspan="1" colspan="1">5/9 (55,6 %)</td><td rowspan="1" colspan="1">76/89 (85,4%) [77,5-93,3]</td></tr><tr><td rowspan="1" colspan="1">Resultado neonatal</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Vivo</td><td rowspan="1" colspan="1">73/74(98,6%)</td><td rowspan="1" colspan="1">7/7 (100%)</td><td rowspan="1" colspan="1">6/9 (66,7%)</td><td rowspan="1" colspan="1">86/90 (95,5%) [91,1-99,8]</td></tr><tr><td rowspan="1" colspan="1">Muerto</td><td rowspan="1" colspan="1">1/74 (1,4%)</td><td rowspan="1" colspan="1">0/7 (0,0%)</td><td rowspan="1" colspan="1">3/9 (33,3%)</td><td rowspan="1" colspan="1">4/90 (4,4%) [0,0-24,5]</td></tr><tr><td rowspan="1" colspan="1">Test de Apgar (1&#x02019; y 5&#x02019;)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">5-9</td><td rowspan="1" colspan="1">0/57 (0,0%)</td><td rowspan="1" colspan="1">2/7 (28,6%)</td><td rowspan="1" colspan="1">0/2 (0%)</td><td rowspan="1" colspan="1">2/66 (3,0%) [0,0-26,7]</td></tr><tr><td rowspan="1" colspan="1">5-7</td><td rowspan="1" colspan="1">0/57 (0,0%)</td><td rowspan="1" colspan="1">1/7 (13,3%)</td><td rowspan="1" colspan="1">0/2 (0%)</td><td rowspan="1" colspan="1">1/66 (1,5%) [0,0-25,3]</td></tr><tr><td rowspan="1" colspan="1">6-8</td><td rowspan="1" colspan="1">0/57 (0,0%)</td><td rowspan="1" colspan="1">0/7 (0,0%)</td><td rowspan="1" colspan="1">1/2 (50%)</td><td rowspan="1" colspan="1">1/66 (1,5%) [0,0-25,3]</td></tr><tr><td rowspan="1" colspan="1">8-9</td><td rowspan="1" colspan="1">5/57 (8,8%)</td><td rowspan="1" colspan="1">0/7 (0,0%)</td><td rowspan="1" colspan="1">0/2 (0%)</td><td rowspan="1" colspan="1">5/66 (7,6%) [0,0-30,8]</td></tr><tr><td rowspan="1" colspan="1">7-8</td><td rowspan="1" colspan="1">2/57 (3,5%)</td><td rowspan="1" colspan="1">1/7 (13,3%)</td><td rowspan="1" colspan="1">0/2 (0%)</td><td rowspan="1" colspan="1">3/66 (4,5%) [0,0-27,9]</td></tr><tr><td rowspan="1" colspan="1">8-10</td><td rowspan="1" colspan="1">1/57 (1,7%)</td><td rowspan="1" colspan="1">0/7 (0,0%)</td><td rowspan="1" colspan="1">0/2 (0%)</td><td rowspan="1" colspan="1">1/66 (1,5%) [0,0-25,3]</td></tr><tr><td rowspan="1" colspan="1">9-9</td><td rowspan="1" colspan="1">0/57 (0,0%)</td><td rowspan="1" colspan="1">1/7 (13,3%)</td><td rowspan="1" colspan="1">0/2 (0%)</td><td rowspan="1" colspan="1">1/66 (1,5%) [0,0-25,3]</td></tr><tr><td rowspan="1" colspan="1">9-10</td><td rowspan="1" colspan="1">30/57 (52,6%)</td><td rowspan="1" colspan="1">2/7 (28,6%)</td><td rowspan="1" colspan="1">1/2 (50%)</td><td rowspan="1" colspan="1">33/66 (50,0%) [32,9-67,0]</td></tr><tr><td rowspan="1" colspan="1">10-10</td><td rowspan="1" colspan="1">15/57 (26,3%)</td><td rowspan="1" colspan="1">0/7 (0,0%)</td><td rowspan="1" colspan="1">0/2 (0,0%)</td><td rowspan="1" colspan="1">15/66 (22,7%) [1,5-43,9]</td></tr><tr><td rowspan="1" colspan="1">Transmisi&#x000f3;n</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Vertical</td><td rowspan="1" colspan="1">0/66 (0,0%)</td><td rowspan="1" colspan="1">0/7 (0,0%)</td><td rowspan="1" colspan="1">0/6 (0,0%)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Leche materna</td><td rowspan="1" colspan="1">0/6 (0,0%)</td><td rowspan="1" colspan="1">0/2 (0,0%)</td><td rowspan="1" colspan="1">0/2 (0,0%)</td><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="TF4-1"><p>SA= Semanas de Amenorrea; VM= Ventilaci&#x000f3;n Mec&#x000e1;nica; RPM= Rotura Prematura de Membranas; RPBF= Riesgo de P&#x000e9;rdida de Bienestar Fetal APP= Amenaza de Parto Prematuro; RCIR= Restricci&#x000f3;n del Crecimiento Intrauterino.</p></fn></table-wrap-foot></table-wrap><p><bold>Sintomatolog&#x000ed;a general asociada a la patolog&#x000ed;a</bold>. Como se aprecia en la <xref rid="T5" ref-type="table">tabla 5</xref> [<xref rid="ref8" ref-type="bibr">8</xref>, <xref rid="ref26" ref-type="bibr">26</xref>-<xref rid="ref34" ref-type="bibr">34</xref>], la fiebre en un 85,9% (n=55) de los casos y la tos en un 32,9% (n=26) fueron los s&#x000ed;ntomas m&#x000e1;s caracter&#x000ed;sticos de las gestantes que enfermaron por SARS-CoV-2, resultando ocasional, la aparici&#x000f3;n de diarrea con un 8,9% (n=7). La neumon&#x000ed;a fue padecida por 75,7% (n=53) de las gestantes y esta fue de car&#x000e1;cter leve en la mayor&#x000ed;a de los casos, ya que solo 4,3% (n=3) de las gestantes precisaron de ventilaci&#x000f3;n mec&#x000e1;nica e ingreso en UCI. En este &#x000fa;ltimo dato cabe destacar que en el art&#x000ed;culo de Zhu et. al. [<xref rid="ref26" ref-type="bibr">26</xref>] no especifica qu&#x000e9; gestantes tuvieron neumon&#x000ed;a y si alguna de ellas precis&#x000f3; o no de ventilaci&#x000f3;n asistida.</p><table-wrap id="T5" orientation="portrait" position="float"><label>Tabla 5</label><caption><p>Caracter&#x000ed;sticas cl&#x000ed;nicas de las madres diagnosticadas de SARS-CoV-2 y resultados neonatales</p></caption><table frame="border" rules="groups"><thead valign="top"><tr><th rowspan="1" colspan="1"/><th colspan="11" rowspan="1">SARS-CoV-2</th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">Chen et al [<xref rid="ref30" ref-type="bibr">30</xref>]<break/>N=9</th><th rowspan="1" colspan="1">Liu et al. [<xref rid="ref29" ref-type="bibr">29</xref>]<break/>N=13</th><th rowspan="1" colspan="1">Wang et al [<xref rid="ref32" ref-type="bibr">32</xref>] <break/>N=1</th><th rowspan="1" colspan="1">Zhu et al. [<xref rid="ref26" ref-type="bibr">26</xref>]<break/>N=8</th><th rowspan="1" colspan="1">Chen et al. [<xref rid="ref27" ref-type="bibr">27</xref>]<break/>N=5</th><th rowspan="1" colspan="1">Zambrano et al. [<xref rid="ref28" ref-type="bibr">28</xref>]<break/>N=1</th><th rowspan="1" colspan="1">Yu et al. [<xref rid="ref34" ref-type="bibr">34</xref>]<break/>N=7</th><th rowspan="1" colspan="1">Liu et al. [<xref rid="ref31" ref-type="bibr">31</xref>]<break/>N=15</th><th rowspan="1" colspan="1">Zhang et al. [<xref rid="ref33" ref-type="bibr">33</xref>]<break/>N=16</th><th rowspan="1" colspan="1">Chen et al. [<xref rid="ref8" ref-type="bibr">8</xref>]<break/>N=4</th><th rowspan="1" colspan="1">TOTAL n/N (%)<break/>N=79</th></tr></thead><tbody valign="top"><tr><td align="center" rowspan="1" colspan="1">Edad</td><td align="center" rowspan="1" colspan="1">26-40<break/>(26&#x000b1;10)</td><td align="center" rowspan="1" colspan="1">22-36<break/>(29&#x000b1;4)</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">2539<break/>(32&#x000b1;4)</td><td align="center" rowspan="1" colspan="1">29-31<break/>(28&#x000b1;1)</td><td align="center" rowspan="1" colspan="1">41</td><td align="center" rowspan="1" colspan="1">3034<break/>(31&#x000b1;1)</td><td align="center" rowspan="1" colspan="1">23 &#x02013; 40<break/>(32&#x000b1;5)</td><td align="center" rowspan="1" colspan="1">(29&#x000b1;3)</td><td align="center" rowspan="1" colspan="1">23 &#x02013; 34<break/>(29&#x000b1;5)</td><td align="center" rowspan="1" colspan="1">22 &#x02013; 41 (31&#x000b1;4)</td></tr><tr><td rowspan="1" colspan="1">SA nacimiento</td><td align="center" rowspan="1" colspan="1">36 -39<break/>(36&#x000b1;4)</td><td align="center" rowspan="1" colspan="1">33 &#x02013; 38<break/>(35&#x000b1;1) <sup>c</sup></td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">33 &#x02013; 39<break/>(35&#x000b1;3) <sup>d</sup></td><td align="center" rowspan="1" colspan="1">39-40<break/>(39&#x000b1;0)</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">3741<break/>(39&#x000b1;1)</td><td align="center" rowspan="1" colspan="1">12 &#x02013; 38<break/>(32&#x000b1;8) <sup>c</sup></td><td align="center" rowspan="1" colspan="1">(38&#x000b1;1)</td><td align="center" rowspan="1" colspan="1">37 &#x02013; 39<break/>(37&#x000b1;1)</td><td align="center" rowspan="1" colspan="1">26 &#x02013; 41 (36&#x000b1;3)</td></tr><tr><td rowspan="1" colspan="1">Sintomatolog&#x000ed;a General Gestante</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Fiebre</td><td align="center" rowspan="1" colspan="1">7/9</td><td align="center" rowspan="1" colspan="1">10/13</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">9/9</td><td align="center" rowspan="1" colspan="1">5/5</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">6/7</td><td align="center" rowspan="1" colspan="1">13/15</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">3/4</td><td align="center" rowspan="1" colspan="1">55/64 (85,9%)</td></tr><tr><td rowspan="1" colspan="1">Mialgia</td><td align="center" rowspan="1" colspan="1">3/9</td><td align="center" rowspan="1" colspan="1">0/13</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/9</td><td align="center" rowspan="1" colspan="1">0/5</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">0/7</td><td align="center" rowspan="1" colspan="1">9/15</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">2/4</td><td align="center" rowspan="1" colspan="1">15/64 (23,4%)</td></tr><tr><td rowspan="1" colspan="1">Diarrea</td><td align="center" rowspan="1" colspan="1">1/9</td><td align="center" rowspan="1" colspan="1">0/13</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">1/9</td><td align="center" rowspan="1" colspan="1">0/5</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">1/7</td><td align="center" rowspan="1" colspan="1">1/15</td><td align="center" rowspan="1" colspan="1">3/16</td><td align="center" rowspan="1" colspan="1">0/4</td><td align="center" rowspan="1" colspan="1">7/79 (8,9%)</td></tr><tr><td rowspan="1" colspan="1">Tos</td><td align="center" rowspan="1" colspan="1">3/9</td><td align="center" rowspan="1" colspan="1">2/13</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">4/9</td><td align="center" rowspan="1" colspan="1">1/5</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">1/7</td><td align="center" rowspan="1" colspan="1">9/15</td><td align="center" rowspan="1" colspan="1">3/16</td><td align="center" rowspan="1" colspan="1">2/4</td><td align="center" rowspan="1" colspan="1">26/79 (32,9%)</td></tr><tr><td rowspan="1" colspan="1">Disnea</td><td align="center" rowspan="1" colspan="1">1/9</td><td align="center" rowspan="1" colspan="1">3/13</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">0/9</td><td align="center" rowspan="1" colspan="1">0/5</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">1/7</td><td align="center" rowspan="1" colspan="1">1/15</td><td align="center" rowspan="1" colspan="1">3/16</td><td align="center" rowspan="1" colspan="1">1/4</td><td align="center" rowspan="1" colspan="1">11/79 (13,9%)</td></tr><tr><td rowspan="1" colspan="1">Neumon&#x000ed;a</td><td align="center" rowspan="1" colspan="1">9/9</td><td align="center" rowspan="1" colspan="1">1/13</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">n/c</td><td align="center" rowspan="1" colspan="1">0/5</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">7/7</td><td align="center" rowspan="1" colspan="1">15/15</td><td align="center" rowspan="1" colspan="1">16/16</td><td align="center" rowspan="1" colspan="1">4/4</td><td align="center" rowspan="1" colspan="1">53/70 (75,7%)</td></tr><tr><td rowspan="1" colspan="1">UCI / VM</td><td align="center" rowspan="1" colspan="1">0/9</td><td align="center" rowspan="1" colspan="1">1/13</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">n/c</td><td align="center" rowspan="1" colspan="1">0/5</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/7</td><td align="center" rowspan="1" colspan="1">0/15</td><td align="center" rowspan="1" colspan="1">1/16</td><td align="center" rowspan="1" colspan="1">0/4</td><td align="center" rowspan="1" colspan="1">3/70 (4,3%)</td></tr><tr><td rowspan="1" colspan="1">Complicaciones Obst&#x000e9;tricas</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">HTA</td><td align="center" rowspan="1" colspan="1">2/9</td><td align="center" rowspan="1" colspan="1">0/10c</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/9</td><td align="center" rowspan="1" colspan="1">1/5</td><td align="center" rowspan="1" colspan="1">1/1a</td><td align="center" rowspan="1" colspan="1">0/7</td><td align="center" rowspan="1" colspan="1">0/11 <sup>c</sup></td><td align="center" rowspan="1" colspan="1">1/16</td><td align="center" rowspan="1" colspan="1">0/4</td><td align="center" rowspan="1" colspan="1">6/74 (8,1%)</td></tr><tr><td rowspan="1" colspan="1">RPM</td><td align="center" rowspan="1" colspan="1">2/9</td><td align="center" rowspan="1" colspan="1">1/10 <sup>c</sup></td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">3/9</td><td align="center" rowspan="1" colspan="1">0/5</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/7</td><td align="center" rowspan="1" colspan="1">0/11 <sup>c</sup></td><td align="center" rowspan="1" colspan="1">3/16</td><td align="center" rowspan="1" colspan="1">0/4</td><td align="center" rowspan="1" colspan="1">9/74 (12,1%)</td></tr><tr><td rowspan="1" colspan="1">Coinfecci&#x000f3;n</td><td align="center" rowspan="1" colspan="1">1/9</td><td align="center" rowspan="1" colspan="1">0/10 <sup>c</sup></td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/9</td><td align="center" rowspan="1" colspan="1">0/5</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/7</td><td align="center" rowspan="1" colspan="1">0/11 <sup>c</sup></td><td align="center" rowspan="1" colspan="1">0/16</td><td align="center" rowspan="1" colspan="1">0/4</td><td align="center" rowspan="1" colspan="1">1/74 (1,3%)</td></tr><tr><td rowspan="1" colspan="1">RPBF</td><td align="center" rowspan="1" colspan="1">2/9</td><td align="center" rowspan="1" colspan="1">3/10 <sup>c</sup></td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">6/9</td><td align="center" rowspan="1" colspan="1">1/5</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/7</td><td align="center" rowspan="1" colspan="1">0/11 <sup>c</sup></td><td align="center" rowspan="1" colspan="1">1/16</td><td align="center" rowspan="1" colspan="1">0/4</td><td align="center" rowspan="1" colspan="1">14/74 (18,9%)</td></tr><tr><td rowspan="1" colspan="1">APP</td><td align="center" rowspan="1" colspan="1">4/9a</td><td align="center" rowspan="1" colspan="1">6/10 <sup>c</sup></td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">5/9</td><td align="center" rowspan="1" colspan="1">0/5</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">0/7</td><td align="center" rowspan="1" colspan="1">0/11 <sup>c</sup></td><td align="center" rowspan="1" colspan="1">1/16</td><td align="center" rowspan="1" colspan="1">0/4</td><td align="center" rowspan="1" colspan="1">18/74 (24,3%)</td></tr><tr><td rowspan="1" colspan="1">Hemorragias</td><td align="center" rowspan="1" colspan="1">0/9</td><td align="center" rowspan="1" colspan="1">0/10 <sup>c</sup></td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">2/9</td><td align="center" rowspan="1" colspan="1">0/5</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/7</td><td align="center" rowspan="1" colspan="1">1/11 <sup>c, f</sup></td><td align="center" rowspan="1" colspan="1">0/16</td><td align="center" rowspan="1" colspan="1">1/4f</td><td align="center" rowspan="1" colspan="1">3/74 (4,0%)</td></tr><tr><td rowspan="1" colspan="1">RCIR</td><td align="center" rowspan="1" colspan="1">0/5</td><td align="center" rowspan="1" colspan="1">0/10 <sup>c</sup></td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/9</td><td align="center" rowspan="1" colspan="1">0/5</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/7</td><td align="center" rowspan="1" colspan="1">0/11 <sup>c</sup></td><td align="center" rowspan="1" colspan="1">0/16</td><td align="center" rowspan="1" colspan="1">0/4</td><td align="center" rowspan="1" colspan="1">0/74 (0%)</td></tr><tr><td rowspan="1" colspan="1">Muerte Materna</td><td align="center" rowspan="1" colspan="1">0/9</td><td align="center" rowspan="1" colspan="1">0/13</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/9</td><td align="center" rowspan="1" colspan="1">0/5</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/7</td><td align="center" rowspan="1" colspan="1">0/15</td><td align="center" rowspan="1" colspan="1">0/16</td><td align="center" rowspan="1" colspan="1">0/4</td><td align="center" rowspan="1" colspan="1">0/79 (0%)</td></tr><tr><td rowspan="1" colspan="1">Fin de parto</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Parto vaginal</td><td align="center" rowspan="1" colspan="1">0/9</td><td align="center" rowspan="1" colspan="1">0/10 <sup>c</sup></td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">2/9</td><td align="center" rowspan="1" colspan="1">3/5</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">0/7</td><td align="center" rowspan="1" colspan="1">1/11 <sup>c</sup></td><td align="center" rowspan="1" colspan="1">0/16</td><td align="center" rowspan="1" colspan="1">1/4</td><td align="center" rowspan="1" colspan="1">8/73 (11,0%)</td></tr><tr><td rowspan="1" colspan="1">Ces&#x000e1;rea</td><td align="center" rowspan="1" colspan="1">9/9</td><td align="center" rowspan="1" colspan="1">10/10 <sup>c</sup></td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">7/9</td><td align="center" rowspan="1" colspan="1">2/5</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">7/7</td><td align="center" rowspan="1" colspan="1">10/11 <sup>c</sup></td><td align="center" rowspan="1" colspan="1">16/16</td><td align="center" rowspan="1" colspan="1">3/4</td><td align="center" rowspan="1" colspan="1">65/73 (89,0%)</td></tr><tr><td rowspan="1" colspan="1">Resultado neonatal</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Vivo</td><td align="center" rowspan="1" colspan="1">9/9</td><td align="center" rowspan="1" colspan="1">10/10 <sup>c</sup></td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">9/10</td><td align="center" rowspan="1" colspan="1">5/5</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">7/7</td><td align="center" rowspan="1" colspan="1">11/11 <sup>c</sup></td><td align="center" rowspan="1" colspan="1">16/16</td><td align="center" rowspan="1" colspan="1">4/4</td><td align="center" rowspan="1" colspan="1">73/74 98,6%)</td></tr><tr><td rowspan="1" colspan="1">Muerto</td><td align="center" rowspan="1" colspan="1">0/9</td><td align="center" rowspan="1" colspan="1">1/10 <sup>c</sup></td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/10</td><td align="center" rowspan="1" colspan="1">0/5</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/7</td><td align="center" rowspan="1" colspan="1">0/11 <sup>c</sup></td><td align="center" rowspan="1" colspan="1">0/16</td><td align="center" rowspan="1" colspan="1">0/4</td><td align="center" rowspan="1" colspan="1">1/74 (1,4%)</td></tr><tr><td rowspan="1" colspan="1">Test de Apgar (1&#x02019; y 5&#x02019;)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">5-9</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0/57 (0%)</td></tr><tr><td rowspan="1" colspan="1">5-7</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0/57 (0%)</td></tr><tr><td rowspan="1" colspan="1">6-8</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0/57 (0%)</td></tr><tr><td rowspan="1" colspan="1">8-9</td><td align="center" rowspan="1" colspan="1">2/9</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">3/10</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">3/4</td><td align="center" rowspan="1" colspan="1">5/57 (8,8%)</td></tr><tr><td rowspan="1" colspan="1">7-8</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1/10</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">1/4</td><td align="center" rowspan="1" colspan="1">2/57 (3,5%)</td></tr><tr><td rowspan="1" colspan="1">8-10</td><td align="center" rowspan="1" colspan="1">1/9</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1/57 (1,7%)</td></tr><tr><td rowspan="1" colspan="1">9-9</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0/57 (0%)</td></tr><tr><td rowspan="1" colspan="1">9-10</td><td align="center" rowspan="1" colspan="1">6/9</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">5/10</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">7/7</td><td align="center" rowspan="1" colspan="1">11/11 <sup>c</sup></td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">30/57 (52,6%)</td></tr><tr><td rowspan="1" colspan="1">10-10</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">9/10c</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1/10</td><td align="center" rowspan="1" colspan="1">5/5</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">15/57 (26,3%)</td></tr><tr><td rowspan="1" colspan="1">Transmisi&#x000f3;n</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Vertical</td><td align="center" rowspan="1" colspan="1">0/6 <sup>b</sup></td><td align="center" rowspan="1" colspan="1">0/10 <sup>c</sup></td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/10</td><td align="center" rowspan="1" colspan="1">0/5</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/3 <sup>b,e</sup></td><td align="center" rowspan="1" colspan="1">0/11 <sup>c</sup></td><td align="center" rowspan="1" colspan="1">0/16<sup>g</sup></td><td align="center" rowspan="1" colspan="1">0/3 <sup>h</sup></td><td align="center" rowspan="1" colspan="1">0/66 (0%)</td></tr><tr><td rowspan="1" colspan="1">Lactancia materna</td><td align="center" rowspan="1" colspan="1">0/6 <sup>b</sup></td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">0/6 (0%)</td></tr></tbody></table><table-wrap-foot><fn id="TF5-1"><p>SA= Semanas de Amenorrea; VM= Ventilaci&#x000f3;n Mec&#x000e1;nica; RPM= Rotura Prematura de Membranas; RPBF= Riesgo de P&#x000e9;rdida de Bienestar Fetal APP= Amenaza de Parto Prematuro; RCIR= Restricci&#x000f3;n del Crecimiento Intrauterino. NA= No hay datos</p></fn><fn id="TF5-2"><p>aNo relacionado con COVID-19; <sup>b</sup>No testado en algunos pacientes; <sup>c</sup>Los embarazos evolucionaron, sin resultado neonatal; <sup>d</sup>Un embarazo gemelar; <sup>e</sup>Un positivo a las 36 horas; <sup>f</sup>Placenta previa; <sup>g</sup>RN desarrollaron neumon&#x000ed;a postparto (n=3); <sup>h</sup>No consentimiento para realizar la prueba</p></fn></table-wrap-foot></table-wrap><p>En relaci&#x000f3;n con el SARS-CoV (<xref rid="T6" ref-type="table">tabla 6</xref>) [<xref rid="ref17" ref-type="bibr">17</xref>, <xref rid="ref18" ref-type="bibr">18</xref>, <xref rid="ref36" ref-type="bibr">36</xref>, <xref rid="ref38" ref-type="bibr">38</xref>], la fiebre y la mialgia aparecieron en el 100% (n=14) de los casos estudiados. Todas las gestantes, desarrollaron neumon&#x000ed;a y un 42,9% (n=6) precisaron recibir ventilaci&#x000f3;n mec&#x000e1;nica en UCI.</p><table-wrap id="T6" orientation="portrait" position="float"><label>Tabla 6</label><caption><p>Caracter&#x000ed;sticas cl&#x000ed;nicas de las madres diagnosticadas de SARS-CoV y resultados neonatales</p></caption><table frame="border" rules="groups"><thead valign="top"><tr><th rowspan="1" colspan="1"/><th colspan="3" rowspan="1">SARS-CoV</th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">Wong et al. [<xref rid="ref17" ref-type="bibr">17</xref>]<break/>Shek et al. [<xref rid="ref18" ref-type="bibr">18</xref>]<break/>N=12</th><th rowspan="1" colspan="1">Robertson et al.[<xref rid="ref36" ref-type="bibr">36</xref>]<break/>Stockman et al.[<xref rid="ref38" ref-type="bibr">38</xref>]<break/>N=2</th><th rowspan="1" colspan="1">TOTAL<break/>n/N (%)<break/>N=14</th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1">Edad</td><td align="center" rowspan="1" colspan="1">2444 (31&#x000b1;6)</td><td align="center" rowspan="1" colspan="1">36 &#x02013; 38</td><td align="center" rowspan="1" colspan="1">2444 (31&#x000b1;6)</td></tr><tr><td rowspan="1" colspan="1">SA nacimiento</td><td align="center" rowspan="1" colspan="1">312 (5&#x000b1;3)<break/>26 &#x02013; 37 (31&#x000b1;4)</td><td align="center" rowspan="1" colspan="1">38 &#x02013; 36</td><td align="center" rowspan="1" colspan="1">3 &#x02013; 38 (19&#x000b1;15)</td></tr><tr><td rowspan="1" colspan="1">Sintomatolog&#x000ed;a General Gestante</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Fiebre</td><td align="center" rowspan="1" colspan="1">12/12</td><td align="center" rowspan="1" colspan="1">2/2</td><td align="center" rowspan="1" colspan="1">14/14 (100%)</td></tr><tr><td rowspan="1" colspan="1">Mialgia</td><td align="center" rowspan="1" colspan="1">12/12</td><td align="center" rowspan="1" colspan="1">2/2</td><td align="center" rowspan="1" colspan="1">14/14 (100%)</td></tr><tr><td rowspan="1" colspan="1">Diarrea</td><td align="center" rowspan="1" colspan="1">2/12</td><td align="center" rowspan="1" colspan="1">0/2</td><td align="center" rowspan="1" colspan="1">2/14 (14,3%)</td></tr><tr><td rowspan="1" colspan="1">Tos</td><td align="center" rowspan="1" colspan="1">9/12</td><td align="center" rowspan="1" colspan="1">2/2</td><td align="center" rowspan="1" colspan="1">11/14 (78,6%)</td></tr><tr><td rowspan="1" colspan="1">Disnea</td><td align="center" rowspan="1" colspan="1">4/12</td><td align="center" rowspan="1" colspan="1">2/2</td><td align="center" rowspan="1" colspan="1">6/14 (42,9%)</td></tr><tr><td rowspan="1" colspan="1">Neumon&#x000ed;a</td><td align="center" rowspan="1" colspan="1">12/12</td><td align="center" rowspan="1" colspan="1">2/2</td><td align="center" rowspan="1" colspan="1">14/14 (100%)</td></tr><tr><td rowspan="1" colspan="1">UCI /VM</td><td align="center" rowspan="1" colspan="1">4/12</td><td align="center" rowspan="1" colspan="1">2/2</td><td align="center" rowspan="1" colspan="1">6/14 (42,9%)</td></tr><tr><td rowspan="1" colspan="1">Complicaciones Obst&#x000e9;tricas</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">HTA</td><td align="center" rowspan="1" colspan="1">0/5 <sup>a</sup></td><td align="center" rowspan="1" colspan="1">0/2</td><td align="center" rowspan="1" colspan="1">0/7 (0%)</td></tr><tr><td rowspan="1" colspan="1">RPM</td><td align="center" rowspan="1" colspan="1">0/5 <sup>a</sup></td><td align="center" rowspan="1" colspan="1">1/2</td><td align="center" rowspan="1" colspan="1">1/7 (14,3%)</td></tr><tr><td rowspan="1" colspan="1">Coinfecciones</td><td align="center" rowspan="1" colspan="1">4/12b</td><td align="center" rowspan="1" colspan="1">0/2</td><td align="center" rowspan="1" colspan="1">4/7 (57,1%)</td></tr><tr><td rowspan="1" colspan="1">RPBF</td><td align="center" rowspan="1" colspan="1">1/5 <sup>a</sup></td><td align="center" rowspan="1" colspan="1">1/2</td><td align="center" rowspan="1" colspan="1">2/7 (28,5%)</td></tr><tr><td rowspan="1" colspan="1">APP</td><td align="center" rowspan="1" colspan="1">4/5 <sup>a</sup></td><td align="center" rowspan="1" colspan="1">1/2</td><td align="center" rowspan="1" colspan="1">5/7 (71,4%)</td></tr><tr><td rowspan="1" colspan="1">Hemorragia</td><td align="center" rowspan="1" colspan="1">3/12 <sup>c</sup></td><td align="center" rowspan="1" colspan="1">1/2d</td><td align="center" rowspan="1" colspan="1">4/7 (57,1%)</td></tr><tr><td rowspan="1" colspan="1">RCIR</td><td align="center" rowspan="1" colspan="1">2/5 <sup>a</sup></td><td align="center" rowspan="1" colspan="1">0/2</td><td align="center" rowspan="1" colspan="1">2/7 (28,6%)</td></tr><tr><td rowspan="1" colspan="1">Muerte materna</td><td align="center" rowspan="1" colspan="1">3/12</td><td align="center" rowspan="1" colspan="1">0/2</td><td align="center" rowspan="1" colspan="1">3/14 (21,4%)</td></tr><tr><td rowspan="1" colspan="1">Fin de parto</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Parto vaginal</td><td align="center" rowspan="1" colspan="1">1/5 <sup>a</sup></td><td align="center" rowspan="1" colspan="1">1/7 (14,3%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Ces&#x000e1;rea</td><td align="center" rowspan="1" colspan="1">4/5 <sup>a</sup></td><td align="center" rowspan="1" colspan="1">2/2</td><td align="center" rowspan="1" colspan="1">6/7 (85,7%)</td></tr><tr><td rowspan="1" colspan="1">Resultado neonatal</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Vivo</td><td align="center" rowspan="1" colspan="1">5/5 <sup>a</sup></td><td align="center" rowspan="1" colspan="1">2/2</td><td align="center" rowspan="1" colspan="1">7/7 (100%)</td></tr><tr><td rowspan="1" colspan="1">Muerto</td><td align="center" rowspan="1" colspan="1">0/5 <sup>a</sup></td><td align="center" rowspan="1" colspan="1">0/2</td><td align="center" rowspan="1" colspan="1">0/7 (0%)</td></tr><tr><td rowspan="1" colspan="1">Test de Apgar (1&#x02019; y 5&#x02019;)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">5-9</td><td align="center" rowspan="1" colspan="1">2/5 <sup>a</sup></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">2/7 (28,6%)</td></tr><tr><td rowspan="1" colspan="1">5-7</td><td align="center" rowspan="1" colspan="1">1/5 <sup>a</sup></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1/7 (13,3%)</td></tr><tr><td rowspan="1" colspan="1">6-8</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0/7 (0%)</td></tr><tr><td rowspan="1" colspan="1">8-9</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0/7 (0%)</td></tr><tr><td rowspan="1" colspan="1">7-8</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1/2</td><td align="center" rowspan="1" colspan="1">1/7 (13,3%)</td></tr><tr><td rowspan="1" colspan="1">8-10</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0/7 (0%)</td></tr><tr><td rowspan="1" colspan="1">9-9</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1/2</td><td align="center" rowspan="1" colspan="1">1/7 (13,3%)</td></tr><tr><td rowspan="1" colspan="1">9-10</td><td align="center" rowspan="1" colspan="1">2/5 <sup>a</sup></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">2/7 (28,6%)</td></tr><tr><td rowspan="1" colspan="1">10-10</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0/7 (0%)</td></tr><tr><td rowspan="1" colspan="1">Transmisi&#x000f3;n</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Vertical</td><td align="center" rowspan="1" colspan="1">0/5 <sup>a</sup></td><td align="center" rowspan="1" colspan="1">0/2</td><td align="center" rowspan="1" colspan="1">0/7 (0%)</td></tr><tr><td rowspan="1" colspan="1">Leche materna</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">0/2</td><td align="center" rowspan="1" colspan="1">0/2 (0%)</td></tr></tbody></table><table-wrap-foot><fn id="TF6-1"><p>SA=Semanas de Amenorrea; VM= Ventilaci&#x000f3;n mec&#x000e1;nica; RPM= Rotura Prematura de Membranas; RPBF= Riesgo de P&#x000e9;rdida de Bienestar Fetal APP= Amenaza de Parto Prematuro; RCIR= Restricci&#x000f3;n del Crecimiento Intrauterino. NA= No hay datos</p></fn><fn id="TF6-2"><p>aSolo 5 pacientes llegaron a 2&#x000ba; o 3&#x000ba; trimestre; <sup>b</sup>Neumon&#x000ed;a bacteriana y sepsis; <sup>c</sup>Coagulaci&#x000f3;n Intravascular Diseminada (CID); dPlacenta previa (PP)</p></fn></table-wrap-foot></table-wrap><p>Respecto al MERS-CoV (<xref rid="T7" ref-type="table">tabla 7</xref>) [<xref rid="ref12" ref-type="bibr">12</xref>, <xref rid="ref20" ref-type="bibr">20</xref>, <xref rid="ref21" ref-type="bibr">21</xref>, <xref rid="ref36" ref-type="bibr">36</xref>, <xref rid="ref37" ref-type="bibr">37</xref>, <xref rid="ref39" ref-type="bibr">39</xref>], destaca la fiebre en el 100% (n=9) de los casos, la tos y la disnea que se produjo en el 87,5% (n=7) como s&#x000ed;ntomas m&#x000e1;s caracter&#x000ed;sticos. El 100% de las gestantes estudiadas padecieron neumon&#x000ed;a, pero solo la mitad precisaron de ventilaci&#x000f3;n mec&#x000e1;nica.</p><table-wrap id="T7" orientation="portrait" position="float"><label>Tabla 7</label><caption><p>Caracter&#x000ed;sticas cl&#x000ed;nicas de las madres diagnosticadas de MERS-CoV y resultados neonatales</p></caption><table frame="border" rules="groups"><thead valign="top"><tr><th rowspan="1" colspan="1"/><th colspan="6" rowspan="1">MERS-CoV</th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">Jeong et al.[<xref rid="ref35" ref-type="bibr">35</xref>]<break/>Park et al. [<xref rid="ref37" ref-type="bibr">37</xref>]<break/>N=1</th><th rowspan="1" colspan="1">Alserehi et al.[<xref rid="ref39" ref-type="bibr">39</xref>] <break/>N=1</th><th rowspan="1" colspan="1">Assiri et al. [<xref rid="ref21" ref-type="bibr">21</xref>]<break/>N=5</th><th rowspan="1" colspan="1">Malik et al. [<xref rid="ref12" ref-type="bibr">12</xref>]<break/>N=1</th><th rowspan="1" colspan="1">Payne et al. [<xref rid="ref20" ref-type="bibr">20</xref>]<break/>N=1</th><th rowspan="1" colspan="1">TOTAL<break/>n/N (%)<break/>N=9</th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1">Edad</td><td align="center" rowspan="1" colspan="1">39</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">27 &#x02013; 34 (30&#x000b1;6)</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">39</td><td align="center" rowspan="1" colspan="1">27 &#x02013; 39 (33&#x000b1;4)</td></tr><tr><td rowspan="1" colspan="1">SA nacimiento</td><td align="center" rowspan="1" colspan="1">37</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">22 &#x02013; 38 (28&#x000b1;7)</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">22 &#x02013; 38 (29&#x000b1;6)</td></tr><tr><td rowspan="1" colspan="1">Sintomatolog&#x000ed;a General Gestante</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Fiebre</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">5/5</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">9/9 (100%)</td></tr><tr><td rowspan="1" colspan="1">Mialgia</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">1/4 <sup>b</sup></td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">1/8 (12,5%)</td></tr><tr><td rowspan="1" colspan="1">Diarrea</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/4 <sup>b</sup></td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/8 (0%)</td></tr><tr><td rowspan="1" colspan="1">Tos</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">4/4 <sup>b</sup></td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">7/8 (87,5%)</td></tr><tr><td rowspan="1" colspan="1">Disnea</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">3/4 <sup>b</sup></td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">7/8 (87,5%)</td></tr><tr><td rowspan="1" colspan="1">Neumon&#x000ed;a</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">5/5</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">8/8 (100%)</td></tr><tr><td rowspan="1" colspan="1">UCI / VM</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">3/5</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">4/8 (50,0%)</td></tr><tr><td rowspan="1" colspan="1">Complicaciones Obst&#x000e9;tricas</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">HTA</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">1/5</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">1/9 (11,1%)</td></tr><tr><td rowspan="1" colspan="1">RPM</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/5</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/9 (0 %)</td></tr><tr><td rowspan="1" colspan="1">Coinfecciones</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/5</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/9 (0 %)</td></tr><tr><td rowspan="1" colspan="1">RPBF</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/5</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/9 (0 %)</td></tr><tr><td rowspan="1" colspan="1">APP</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/5</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">1/9 (11,1%)</td></tr><tr><td rowspan="1" colspan="1">Hemorragias</td><td align="center" rowspan="1" colspan="1">1/1 <sup>a</sup></td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/5</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">2/9 (22,2%)</td></tr><tr><td rowspan="1" colspan="1">RCIR</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/5</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/9 (0 %)</td></tr><tr><td rowspan="1" colspan="1">Muerte materna</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">2/5</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">3/9 (33,3%)</td></tr><tr><td rowspan="1" colspan="1">Fin de parto</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Parto vaginal</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">3/5</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">4/9 (44,4%)</td></tr><tr><td rowspan="1" colspan="1">Ces&#x000e1;rea</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">2/5</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">5/9 (55,6 %)</td></tr><tr><td rowspan="1" colspan="1">Resultado neonatal</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Vivo</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">3/5</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">6/9 (66,7%)</td></tr><tr><td rowspan="1" colspan="1">Muerto</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">2/5<sup>c</sup></td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">3/9 (33,3%)</td></tr><tr><td rowspan="1" colspan="1">Test de Apgar (1&#x02019; y 5&#x02019;)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">5-9</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">0/2 (0%)</td></tr><tr><td rowspan="1" colspan="1">5-7</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">0/2 (0%)</td></tr><tr><td rowspan="1" colspan="1">6-8</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">1/2 (50%)</td></tr><tr><td rowspan="1" colspan="1">8-9</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">0/2 (0%)</td></tr><tr><td rowspan="1" colspan="1">7-8</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">0/2 (0%)</td></tr><tr><td rowspan="1" colspan="1">8-10</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">0/2 (0%)</td></tr><tr><td rowspan="1" colspan="1">9-9</td><td align="center" rowspan="1" colspan="1">1/1</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">0/2 (0%)</td></tr><tr><td rowspan="1" colspan="1">9-10</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">1/2 (50%)</td></tr><tr><td rowspan="1" colspan="1">10-10</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">0/2 (0%)</td></tr><tr><td rowspan="1" colspan="1">Transmisi&#x000f3;n</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Vertical</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/4d</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">0/6 (0 %)</td></tr><tr><td rowspan="1" colspan="1">Leche materna</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">0/1</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">0/2 (0 %)</td></tr></tbody></table><table-wrap-foot><fn id="TF7-1"><p>SA=Semanas de Amenorrea; VM= Ventilaci&#x000f3;n Mec&#x000e1;nica; RPM= Rotura Prematura de Membranas; RPBF= Riesgo de P&#x000e9;rdida de Bienestar Fetal APP= Amenaza de Parto Prematuro; RCIR= Restricci&#x000f3;n del Crecimiento Intrauterino. NA= No hay datos</p></fn><fn id="TF7-2"><p>aDesprendimiento de Placenta Normoinserta; <sup>b</sup>En uno de los casos solo especifica que tuvo fiebre y neumon&#x000ed;a; <sup>c</sup>Un neonato muri&#x000f3; a las 4 horas; <sup>d</sup>No se realiz&#x000f3; por muerte neonatal 24 semanas.</p></fn></table-wrap-foot></table-wrap><p><bold>Complicaciones obst&#x000e9;tricas de las gestantes</bold>. Las complicaciones obst&#x000e9;tricas en las mujeres que pasaron el COVID-19 durante la gestaci&#x000f3;n son escasas, destacando que se produjo la APP en el 24,3% (n=18) y el Riesgo de P&#x000e9;rdida de Bienestar Fetal (RPBF) en un 18,9% (n=14) como urgencias obst&#x000e9;tricas m&#x000e1;s frecuentes. De estos datos destaca que no se produjo ning&#x000fa;n fallecimiento entres las infectadas por SARS-CoV-2.</p><p>Respecto al SARS-CoV, un 41,7% (n=5) tuvieron un aborto durante el primer trimestre, por ello no tenemos datos de las complicaciones obst&#x000e9;tricas. En el resto de gestantes, la infecci&#x000f3;n se produjo cuando a&#x000fa;n no hab&#x000ed;an llegado a t&#x000e9;rmino, por ello el 71,4% (n=5) padecieron una APP. Las hemorragias preparto ocurrieron en un 57,1% (n=4) y fueron de distinto origen, una fue por Placenta Previa (PP) [<xref rid="ref36" ref-type="bibr">36</xref>, <xref rid="ref38" ref-type="bibr">38</xref>] y las otras tres una Coagulaci&#x000f3;n Intravascular Diseminada (CID) [<xref rid="ref18" ref-type="bibr">18</xref>, <xref rid="ref36" ref-type="bibr">36</xref>]. Una de las complicaciones m&#x000e1;s graves que produjo la neumon&#x000ed;a por SARS-CoV fue la co-infecci&#x000f3;n por sepsis y neumon&#x000ed;a bacteriana que se produjo en el 57,1% (n=4) de las gestantes. El 21,4% (n=3) de las gestantes fallecieron.</p><p>Entre las diagnosticadas por MERS-CoV, destacan tres complicaciones: la hemorragia preparto que se present&#x000f3; en el 22,2% (n=2), la hipertensi&#x000f3;n arterial previa a la infecci&#x000f3;n y la APP en un 11,1% (n=1) respectivamente. La hemorragia que se dio en dos gestantes, una fue por DPPNI y la otra no se especific&#x000f3; [<xref rid="ref20" ref-type="bibr">20</xref>, <xref rid="ref35" ref-type="bibr">35</xref>]. Fallecieron el 33,3% (n=3) de las gestantes estudiadas.</p><p><bold>Fin de parto, resultado neonatal y transmisi&#x000f3;n vertical</bold>. Las gestantes adquirieron la infecci&#x000f3;n por SARS-CoV-2, durante el tercer trimestre [36 semanas (DE&#x000b1;3)] y el 89,0% (n=66) termin&#x000f3; en ces&#x000e1;rea. Se registr&#x000f3; una muerte fetal, de un lactante cuya madre empeor&#x000f3; durante la estancia hospitalaria y precis&#x000f3; ventilaci&#x000f3;n mec&#x000e1;nica [<xref rid="ref29" ref-type="bibr">29</xref>]. El 98,6% (n=73) de los neonatos tuvieron un Apgar superior a 8 tanto al minuto como a los cinco minutos de vida. No se document&#x000f3; ninguna transmisi&#x000f3;n vertical al reci&#x000e9;n nacido. Los datos de transmisi&#x000f3;n vertical se obtuvieron mediante el an&#x000e1;lisis microbiol&#x000f3;gico del l&#x000ed;quido amni&#x000f3;tico, la sangre de cord&#x000f3;n umbilical o la placenta. No se disponen de algunos datos, porque el diagnostico positivo de infecci&#x000f3;n materna a SARS-CoV-2 fue posterior al nacimiento o por no consentimiento paterno para la realizaci&#x000f3;n de las pruebas [<xref rid="ref8" ref-type="bibr">8</xref>]. La transmisi&#x000f3;n del SARS-CoV-2 a trav&#x000e9;s de la leche materna no se produjo en ning&#x000fa;n caso, pero solo se realiz&#x000f3; el an&#x000e1;lisis en el 5,9% (n=6) de las pu&#x000e9;rperas [<xref rid="ref30" ref-type="bibr">30</xref>] y algunas gestaciones no hab&#x000ed;an finalizado cuando se publicaron los trabajos [<xref rid="ref29" ref-type="bibr">29</xref>, <xref rid="ref31" ref-type="bibr">31</xref>].</p><p>Respecto al SARS-CoV, un 85,7% (n=6) de las gestantes que se infectaron durante el tercer trimestre acabaron en ces&#x000e1;rea. Ning&#x000fa;n beb&#x000e9; muri&#x000f3;, aunque un 57,1 % (n=4) tuvieron un Apgar al minuto inferior a 7, que consiguieron estabilizar a los 5 minutos (Apgar superior a 7). No se registr&#x000f3; transmisi&#x000f3;n vertical tras el an&#x000e1;lisis microbiol&#x000f3;gico del neonato, l&#x000ed;quido amni&#x000f3;tico, sangre de cord&#x000f3;n o placenta [<xref rid="ref17" ref-type="bibr">17</xref>, <xref rid="ref18" ref-type="bibr">18</xref>]. La transmisi&#x000f3;n por leche materna tampoco fue detectada [<xref rid="ref36" ref-type="bibr">36</xref>, <xref rid="ref38" ref-type="bibr">38</xref>].</p><p>El MERS-CoV afect&#x000f3; a gestantes en segundo y tercer trimestre [22 &#x02013; 38 (29&#x000b1;6)]. El 55,6% (n=5) de las gestaciones termin&#x000f3; mediante ces&#x000e1;rea. Se produjeron dos muertes prenatales y una a las cuatro horas del nacimiento [<xref rid="ref20" ref-type="bibr">20</xref>, <xref rid="ref21" ref-type="bibr">21</xref>] y s&#x000f3;lo se registr&#x000f3; el Apgar en dos casos [<xref rid="ref12" ref-type="bibr">12</xref>, <xref rid="ref35" ref-type="bibr">35</xref>]. La transmisi&#x000f3;n vertical tampoco se constat&#x000f3; en ninguno de los seis casos analizados [<xref rid="ref21" ref-type="bibr">21</xref>, <xref rid="ref35" ref-type="bibr">35</xref>, <xref rid="ref37" ref-type="bibr">37</xref>, <xref rid="ref39" ref-type="bibr">39</xref>]. En dos casos se analiz&#x000f3; la transmisi&#x000f3;n a trav&#x000e9;s de la leche materna con resultandos negativos [<xref rid="ref35" ref-type="bibr">35</xref>, <xref rid="ref37" ref-type="bibr">37</xref>, <xref rid="ref39" ref-type="bibr">39</xref>].</p></sec><sec id="S4"><title>DISCUSION</title><p>Un siglo despu&#x000e9;s de la pandemia por Influenza A/H1N1 conocida como &#x0201c;gripe espa&#x000f1;ola&#x0201d; y causante de m&#x000e1;s de 40 millones de fallecimientos, la pandemia por SARS-CoV2 ha emergido con una fuerza inusitada poniendo a prueba la capacidad de respuesta de los sistemas sanitarios [<xref rid="ref40" ref-type="bibr">40</xref>], con la desventaja de que no existe por el momento disponibilidad de vacunas o tratamientos espec&#x000ed;ficos para las infecciones por coronavirus [<xref rid="ref15" ref-type="bibr">15</xref>].</p><p>Era conocido que los coronavirus, SARS-CoV y MERS-CoV, causaban complicaciones graves durante el embarazo, por lo que las observaciones extra&#x000ed;das de los casos podr&#x000ed;an ser &#x000fa;tiles para la toma de decisiones cl&#x000ed;nicas y preventivas en el nuevo SARSCoV-2. Los resultados arrojan similitudes y diferencias, pero todos coinciden en el aumento de morbi-mortalidad en la mujer gestante en comparaci&#x000f3;n con la no gestante [<xref rid="ref13" ref-type="bibr">13</xref>, <xref rid="ref15" ref-type="bibr">15</xref>, <xref rid="ref18" ref-type="bibr">18</xref>-<xref rid="ref20" ref-type="bibr">20</xref>, <xref rid="ref41" ref-type="bibr">41</xref>].</p><p>La mayor parte de gestantes infectadas por SARS-CoV2 se encontraban en el tercer trimestre de embarazo, probablemente porque exist&#x000ed;a un gran n&#x000fa;mero de pacientes asintom&#x000e1;ticas [<xref rid="ref31" ref-type="bibr">31</xref>]. En una reciente publicaci&#x000f3;n [<xref rid="ref42" ref-type="bibr">42</xref>] se realiz&#x000f3; a todas las mujeres en trabajo de parto un examen de detecci&#x000f3;n al ingreso mediante una prueba nasofar&#x000ed;ngea, resultando que la mayor&#x000ed;a positivas a SARS-CoV-2 no presentaban ning&#x000fa;n s&#x000ed;ntoma de la enfermedad.</p><p>El monitoreo de todas las gestantes desde el inicio es importante, dado que en otras infecciones como la gripe o el SARS, estas patolog&#x000ed;as se relacionaron con abortos espont&#x000e1;neos [<xref rid="ref11" ref-type="bibr">11</xref>], Restricciones del Crecimiento Intrauterino (RCIR) [<xref rid="ref18" ref-type="bibr">18</xref>] y APP [<xref rid="ref14" ref-type="bibr">14</xref>].</p><p>El manejo de las gestantes con SARS-CoV-2 debe correr a cargo de un equipo multidisciplinar que permita mantener el control materno-fetal y detectar el inicio de una posible APP [<xref rid="ref26" ref-type="bibr">26</xref>, <xref rid="ref29" ref-type="bibr">29</xref>, <xref rid="ref30" ref-type="bibr">30</xref>, <xref rid="ref43" ref-type="bibr">43</xref>]. En esta revisi&#x000f3;n, una cuarta parte de las gestantes con SARS-CoV-2 desarrollaron una APP, con las siguientes consecuencias de bajo peso fetal e ingreso en neonatos [<xref rid="ref26" ref-type="bibr">26</xref>, <xref rid="ref28" ref-type="bibr">28</xref>-<xref rid="ref30" ref-type="bibr">30</xref>, <xref rid="ref32" ref-type="bibr">32</xref>, <xref rid="ref33" ref-type="bibr">33</xref>], aunque no est&#x000e1;n directamente relacionados con el virus sino por lo general, consecuencia de patolog&#x000ed;a materna o RPBF. En segundo lugar, una quinta parte documentaron anormalidades en el registro cardiotocogr&#x000e1;fico con RPBF [<xref rid="ref26" ref-type="bibr">26</xref>, <xref rid="ref30" ref-type="bibr">30</xref>] y en el grupo de gestante a t&#x000e9;rmino se observ&#x000f3; Rotura Prematura de Membranas [<xref rid="ref33" ref-type="bibr">33</xref>].</p><p>La sintomatolog&#x000ed;a com&#x000fa;n de los tres coronavirus fue la fiebre, con el SARS-CoV-2 y el SARS-CoV la aparici&#x000f3;n de mialgia y con el MERS-CoV la tos [<xref rid="ref30" ref-type="bibr">30</xref>, <xref rid="ref31" ref-type="bibr">31</xref>]. La fiebre se produjo durante el postparto en algunas gestantes y la sintomatolog&#x000ed;a respiratoria fue leve. La neumon&#x000ed;a como patolog&#x000ed;a coincidente entre los tres, fue m&#x000e1;s leve en el caso del SARS-CoV-2 [<xref rid="ref44" ref-type="bibr">44</xref>].</p><p>El fallo en la funci&#x000f3;n respiratoria, que en algunos casos precisa la intubaci&#x000f3;n endotraqueal e ingreso en UCI tiene implicaciones para la salud materno-fetal [<xref rid="ref45" ref-type="bibr">45</xref>]. Con los antecedentes de los que disponemos en otros coronavirus, debemos monitorizar los casos de SARS-CoV-2, ya que la tasa de letalidad por SARS-CoV ascendi&#x000f3; al 25% y para el MERS-CoV a un 27% [<xref rid="ref17" ref-type="bibr">17</xref>, <xref rid="ref21" ref-type="bibr">21</xref>, <xref rid="ref35" ref-type="bibr">35</xref>].</p><p>Todas las gestantes infectadas por MERS-CoV y SARSCoV desarrollaron una neumon&#x000ed;a, precisando ingreso en UCI la mitad de las pacientes con MERS-CoV y la totalidad de las pacientes con SARS-CoV [<xref rid="ref12" ref-type="bibr">12</xref>, <xref rid="ref17" ref-type="bibr">17</xref>, <xref rid="ref36" ref-type="bibr">36</xref>]. La coinfecci&#x000f3;n producida en gestantes con neumon&#x000ed;a por SARS produjo m&#x000e1;s mortalidad materna asociada [<xref rid="ref18" ref-type="bibr">18</xref>]. En el caso de las gestantes con COVID-19 algo m&#x000e1;s de la mitad desarroll&#x000f3; neumon&#x000ed;a, pero esta fue m&#x000e1;s leve, requiriendo ingreso en UCI pocos casos [<xref rid="ref30" ref-type="bibr">30</xref>, <xref rid="ref31" ref-type="bibr">31</xref>, <xref rid="ref33" ref-type="bibr">33</xref>]. Por lo tanto, la neumon&#x000ed;a materna genera en todos los coronavirus resultados obst&#x000e9;tricos adversos como APP, RCIR o muerte fetal intrauterina. Durante la pandemia de gripe de 1918, las complicaciones m&#x000e1;s frecuentes fueron el aborto espont&#x000e1;neo y la APP. Entonces se observ&#x000f3; que m&#x000e1;s de la mitad de las gestantes con gripe y neumon&#x000ed;a asociadas, no llegaron a t&#x000e9;rmino [<xref rid="ref46" ref-type="bibr">46</xref>].</p><p>En la muestra de gestantes con SARS-CoV-2 la forma principal de fin de parto fue la ces&#x000e1;rea en un (89,0 %) [<xref rid="ref8" ref-type="bibr">8</xref>, <xref rid="ref29" ref-type="bibr">29</xref>, <xref rid="ref30" ref-type="bibr">30</xref>, <xref rid="ref33" ref-type="bibr">33</xref>, <xref rid="ref34" ref-type="bibr">34</xref>] porcentaje coincidente con la muestra del SARSCoV y en menor medida con el MERS-CoV, que tuvo partos vaginales casi en la mitad de los casos [<xref rid="ref20" ref-type="bibr">20</xref>, <xref rid="ref21" ref-type="bibr">21</xref>]. Este elevado porcentaje de ces&#x000e1;reas es motivo de preocupaci&#x000f3;n, ya que la mayor&#x000ed;a son electivas y no siempre estuvieron justificadas [<xref rid="ref47" ref-type="bibr">47</xref>].</p><p>La transmisi&#x000f3;n vertical de la infecci&#x000f3;n se produjo a trav&#x000e9;s de la placenta intra&#x000fa;tero o durante el desarrollo del parto. El riesgo de ingesti&#x000f3;n de secreciones cervicovaginales es superior en el parto vaginal, por lo que este podr&#x000ed;a ser uno de los factores que podr&#x000ed;a explicar la no transmisi&#x000f3;n al feto en los casos de COVID-19. Por tanto, el riesgo de no transmisi&#x000f3;n vertical no puede confirmarse, aunque en la mayor&#x000ed;a de las pruebas realizadas tras el parto en las gestantes con SARS-CoV-2, no se evidenci&#x000f3; infecci&#x000f3;n neonatal [<xref rid="ref29" ref-type="bibr">29</xref>, <xref rid="ref31" ref-type="bibr">31</xref>, <xref rid="ref48" ref-type="bibr">48</xref>]. En el estudio de Yu et. al. [<xref rid="ref34" ref-type="bibr">34</xref>], la prueba de &#x000e1;cido nucleico en la garganta de un reci&#x000e9;n nacido fue positiva a las 36h del nacimiento, aunque no se especifica el modo de contagio, ya que todas las gestantes de la muestra se encontraban en el &#x000fa;ltimo trimestre. En otro estudio Chen et. al. [<xref rid="ref8" ref-type="bibr">8</xref>]. cuatro de los casos resultaron negativos, aunque en dos de ellos se desarroll&#x000f3; una erupci&#x000f3;n al nacer que desapareci&#x000f3; a los pocos d&#x000ed;as.</p><p>Se ha demostrado que la transmisi&#x000f3;n a profesionales o personal del entorno cercano es posible [<xref rid="ref49" ref-type="bibr">49</xref>]. Los lactantes de madres positivas a SARS-CoV-2 no estaban infectados al nacimiento, aunque solo se documentaron en 6 casos [<xref rid="ref30" ref-type="bibr">30</xref>] y no desarrollaron la sintomatolog&#x000ed;a caracter&#x000ed;stica de sus madres (disnea, fiebre o mialgia) [<xref rid="ref8" ref-type="bibr">8</xref>]. Con los otros dos coronavirus, tampoco hubo constancia de infecci&#x000f3;n a trav&#x000e9;s de la lactancia materna, pero en el caso del SARS-CoV en sangre del cord&#x000f3;n umbilical y en leche materna aparecieron anticuerpos, lo que hace pensar en una posible inmunidad pasiva [<xref rid="ref36" ref-type="bibr">36</xref>, <xref rid="ref38" ref-type="bibr">38</xref>]. Sin embargo, esta inmunidad pasiva se ha documentado recientemente en un estudio con madres infectadas con SARS-CoV-2, que habla sobre la transferencia de anticuerpos (IgA) en leche materna.[<xref rid="ref50" ref-type="bibr">50</xref>]. La inmunidad a trav&#x000e9;s de la placenta (sobre todo en el tercer trimestre) y de la leche materna [<xref rid="ref51" ref-type="bibr">51</xref>] sugiere que se podr&#x000ed;a permitir a las mujeres infectadas el amamantamiento, manteniendo medidas de protecci&#x000f3;n como higiene de manos y mascarilla facial [<xref rid="ref52" ref-type="bibr">52</xref>].</p><p>Independientemente, del tipo de parto, ya sea por ces&#x000e1;rea o vaginal, las valoraciones del Apgar de los reci&#x000e9;n nacidos de madres con COVID-19, son en todos los casos superiores a 8 (al 1 min y 5 min) [<xref rid="ref27" ref-type="bibr">27</xref>, <xref rid="ref34" ref-type="bibr">34</xref>]. Con los otros dos coronavirus, existen valoraciones inferiores [<xref rid="ref21" ref-type="bibr">21</xref>].</p><p>La muerte intrauterina solo se document&#x000f3; en un caso de SARS-CoV-2 [<xref rid="ref29" ref-type="bibr">29</xref>] y ning&#x000fa;n caso de mortalidad fetal [<xref rid="ref30" ref-type="bibr">30</xref>, <xref rid="ref31" ref-type="bibr">31</xref>] a diferencia del MERS-CoV en un tercio de los casos [<xref rid="ref16" ref-type="bibr">16</xref>, <xref rid="ref20" ref-type="bibr">20</xref>, <xref rid="ref29" ref-type="bibr">29</xref>].</p><p>Con todo lo expuesto, existen todav&#x000ed;a lagunas en el conocimiento sobre las consecuencias para la madre y el feto, pero los antecedentes cl&#x000ed;nicos de otros coronavirus nos hacen pensar que existen m&#x000e1;s complicaciones durante la gestaci&#x000f3;n (APP, RCIR, hemorragias del tercer trimestre, hospitalizaciones), el parto (RPBF, ces&#x000e1;reas electivas y urgentes) y en el reci&#x000e9;n nacido (prematuridad, dificultades respiratorias al nacimiento) [<xref rid="ref26" ref-type="bibr">26</xref>,<xref rid="ref35" ref-type="bibr">35</xref>,<xref rid="ref53" ref-type="bibr">53</xref>]. Sin embargo, es muy alentador que las &#x000fa;ltimas revisiones muestren una evoluci&#x000f3;n muy favorable de las mujeres enfermas por COVID-19, con una tasa de mortalidad materna muy baja o casi nula, con un solo caso [<xref rid="ref54" ref-type="bibr">54</xref>-<xref rid="ref56" ref-type="bibr">56</xref>].</p><p>Se&#x000f1;alamos como limitaci&#x000f3;n de esta revisi&#x000f3;n que todos los art&#x000ed;culos son de tipo observacional, retrospectivos de series de casos o de reporte de un caso, en los que la fuente de datos fueron las historias cl&#x000ed;nicas, por lo que no es posible establecer relaci&#x000f3;n de causalidad. Nuestro estudio compara los tres coronavirus como la revisi&#x000f3;n realizada recientemente por Di Mascio et .al. [<xref rid="ref57" ref-type="bibr">57</xref>], pero difiere en el mayor n&#x000fa;mero de casos analizados de SARS-CoV-2 y la muestra de los casos de MERS, los trabajos de Jeong et. al. [<xref rid="ref35" ref-type="bibr">35</xref>] y Park et. al. [<xref rid="ref37" ref-type="bibr">37</xref>] no han sido analizados por separado, por tratarse de la misma gestante.</p><p>A pesar de las limitaciones, en estos momentos de emergencia sanitaria por un nuevo agente infeccioso, este tipo de estudios (revisi&#x000f3;n exploratoria) [<xref rid="ref58" ref-type="bibr">58</xref>] pueden representar la mejor evidencia disponible para informar de la pr&#x000e1;ctica cl&#x000ed;nica y sus resultados orientar futuras investigaciones.</p><p>Con las limitaciones propias de un acontecimiento que est&#x000e1; en constante evoluci&#x000f3;n, puede afirmarse que las gestantes infectadas por alguno de los tres coronavirus producen una neumon&#x000ed;a con sintomatolog&#x000ed;a muy similar, resultando m&#x000e1;s leve en el SARS-CoV-2. Las complicaciones obst&#x000e9;tricas son frecuentes y atribuibles a que la infecci&#x000f3;n se produce cuando la gestaci&#x000f3;n a&#x000fa;n no ha llegado a t&#x000e9;rmino. Aun as&#x000ed;, los resultados neonatales son favorables en su mayor&#x000ed;a, destacando que no se encuentra evidencia de transmisi&#x000f3;n vertical al final del embarazo. Ser&#x000e1; necesario seguir documentando casos de gestantes infectadas, para aumentar el conocimiento y minimizar los efectos indeseables en este grupo de poblaci&#x000f3;n vulnerable.</p></sec></body><back><sec id="S5"><title>FINANCIACI&#x000d3;N</title><p>Los autores declaran que no han recibido financiaci&#x000f3;n para la realizaci&#x000f3;n de este estudio.</p></sec><sec id="S6" sec-type="COI-statement"><title>CONFLICTO DE INTERESES</title><p>Los autores declaran no tener conflictos de intereses.</p></sec><ref-list><ref id="ref1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chattu</surname><given-names>VK</given-names></name>, <name name-style="western"><surname>Yaya</surname><given-names>S</given-names></name></person-group>
<article-title>Emerging infectious diseases and outbreaks: im-plications for women&#x02019;s reproductive health and rights in resource-poor settings</article-title>. <source>Reprod Health</source>. <year>2020</year>;<volume>17</volume>(<issue>1</issue>):43. DOI: <pub-id pub-id-type="doi">10.1186/s12978-</pub-id>
<fpage>20</fpage>-<lpage>0899</lpage>-y.<pub-id pub-id-type="pmid">32005263</pub-id></mixed-citation></ref><ref id="ref2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gellin</surname><given-names>BG</given-names></name>, <name name-style="western"><surname>Qadri</surname><given-names>F</given-names></name></person-group>
<article-title>Preparing for the unpredictable: The con-tinuing need for pandemic influenza preparedness</article-title>. <source>Vaccine</source>. <year>2016</year>;<volume>34</volume>(<issue>45</issue>):<fpage>5391</fpage>-<lpage>5392</lpage>. DOI: <pub-id pub-id-type="doi">10.1016/j.vaccine.2016.09.023</pub-id><pub-id pub-id-type="pmid">27682508</pub-id></mixed-citation></ref><ref id="ref3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krubiner</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Faden</surname><given-names>RR</given-names></name>, <name name-style="western"><surname>Karron</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Little</surname><given-names>MO</given-names></name>, <name name-style="western"><surname>Lyerly</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Abramson</surname><given-names>JS</given-names></name>, <etal>et al</etal></person-group>
<article-title>Pregnant women &#x00026; vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response</article-title>. <source>Vaccine</source>. <year>2019</year> DOI: <pub-id pub-id-type="doi">10.1016/j.vaccine.2019.01.011</pub-id></mixed-citation></ref><ref id="ref4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Yuan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kok</surname><given-names>K</given-names></name>, <name name-style="western"><surname>To</surname><given-names>KK</given-names></name>, <name name-style="western"><surname>Chu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>J</given-names></name>, <etal>et al</etal></person-group>
<article-title>A familial clus-ter of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster</article-title>. <source>Lancet</source>. <year>2020</year>;<volume>395</volume>(<issue>10223</issue>):<fpage>514</fpage>-<lpage>23</lpage>. DOI:<pub-id pub-id-type="doi">10.1016/S0140-</pub-id>
<pub-id pub-id-type="doi">10.1016/s0140-6736(20)30154-9</pub-id>.<pub-id pub-id-type="pmid">31986261</pub-id></mixed-citation></ref><ref id="ref5"><label>5</label><mixed-citation publication-type="web"><article-title>WHO Director-General&#x02019;s opening remarks at the media briefing on COVID-19 11 March 2020</article-title> [Internet]. [consultado el 10 de abril de 2020]. Disponible en: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020">https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020</ext-link>.</mixed-citation></ref><ref id="ref6"><label>6</label><mixed-citation publication-type="web"><article-title>Ministerio de Sanidad, Consumo y Bienestar Social Profesionales Enfermedad por nuevo coronavirus, COVID-19 [Internet]</article-title>. [consultado el 4 de abril de 2020]. Disponible en: <ext-link ext-link-type="uri" xlink:href="https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/20200404_ITCoronavirus.pdf">https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/20200404_ITCoronavirus.pdf</ext-link></mixed-citation></ref><ref id="ref7"><label>7</label><mixed-citation publication-type="web"><article-title>Informe n&#x000ba; 20. Situaci&#x000f3;n de COVID-19 en Espa&#x000f1;a a 3 de abril de 2020</article-title>. <source>Equipo COVID-19. RENAVE. (ISCIII) [Internet]</source>. [consultado el 14 de abril del 2020]. Disponible en: <ext-link ext-link-type="uri" xlink:href="https://www.isciii.es/Que-Hacemos/Servicios/VigilanciaSaludPublicaRENAVE/Enfermeda-desTransmisibles/Documents/INFORMES/Informes%20COVID-19/Informe%20n%C2%BA%2020.%20Situaci%C3%B3n%20de%20COVID-19%20en%20Espa%C3%B1a%20a%203%20de%20abril%20de%202020.pdf">https://www.isciii.es/Que-Hacemos/Servicios/VigilanciaSaludPublicaRENAVE/Enfermeda-desTransmisibles/Documents/INFORMES/Informes%20COVID-19/Informe%20n%C2%BA%2020.%20Situaci%C3%B3n%20de%20COVID-19%20en%20Espa%C3%B1a%20a%203%20de%20abril%20de%202020.pdf</ext-link></mixed-citation></ref><ref id="ref8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Peng</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zeng</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>H</given-names></name>, <etal>et al</etal></person-group>
<article-title>Infants Born to Mothers with a New Coronavirus (COVID-19)</article-title>. <source>Front Pediatr</source>. <year>2020</year>;<volume>8</volume>:<fpage>104</fpage> DOI: <pub-id pub-id-type="doi">10.3389/fped.2020.00104</pub-id>.<pub-id pub-id-type="pmid">32266184</pub-id></mixed-citation></ref><ref id="ref9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jamieson</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Jernigan</surname><given-names>DB</given-names></name>, <name name-style="western"><surname>Ellis</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Treadwell</surname><given-names>TA</given-names></name></person-group>
<article-title>Emerging infections and pregnancy: West Nile virus, monkeypox, severe acute respira-tory syndrome, and bioterrorism</article-title>. <source>Clin Perinatol</source>. <year>2005</year>;<volume>32</volume>(<issue>3</issue>):<fpage>765</fpage>-<lpage>76</lpage>. DOI:<pub-id pub-id-type="doi">10.1016/j.clp.2005.04.008</pub-id>.<pub-id pub-id-type="pmid">16085032</pub-id></mixed-citation></ref><ref id="ref10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rasmussen</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Jamieson</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Uyeki</surname><given-names>TM</given-names></name></person-group>
<article-title>Effects of influenza on pregnant women and infants</article-title>. <source>Am J Obstet Gynecol</source>. <year>2012</year>;<volume>207</volume>(<issue>3 Suppl</issue>):<fpage>S3</fpage>-<lpage>8</lpage>. DOI: <pub-id pub-id-type="doi">10.1016/j.ajog.2012.06.068</pub-id>.<pub-id pub-id-type="pmid">22920056</pub-id></mixed-citation></ref><ref id="ref11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiao</surname><given-names>J</given-names></name></person-group>
<article-title>Under the epidemic situation of COVID-19, should special attention to pregnant women be given?</article-title>
<source>J Med Virol</source>. <year>2020</year> DOI: <pub-id pub-id-type="doi">10.1002/jmv.25771</pub-id>.</mixed-citation></ref><ref id="ref12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malik</surname><given-names>A</given-names></name>, <name name-style="western"><surname>El Masry</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Ravi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sayed</surname><given-names>F</given-names></name></person-group>
<article-title>Middle East Respiratory Syndrome Coronavirus during Pregnancy, Abu Dhabi, United Arab Emirates, 2013</article-title>. <source>Emerg Infect Dis</source>. <year>2016</year>;<volume>22</volume>(<issue>3</issue>):<fpage>515</fpage>-<lpage>7</lpage>. DOI:<pub-id pub-id-type="doi">10.3201/eid2203.151049</pub-id><pub-id pub-id-type="pmid">26890613</pub-id></mixed-citation></ref><ref id="ref13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Longman</surname><given-names>RE</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>TR</given-names></name></person-group>
<article-title>Viral respiratory disease in pregnan-cy</article-title>. <source>Curr Opin Obstet Gynecol</source>. <year>2007</year>;<volume>19</volume>(<issue>2</issue>):<fpage>120</fpage>-<lpage>5</lpage>. DOI: <pub-id pub-id-type="doi">10.1097/GCO.0b013e328028fdc7</pub-id>.<pub-id pub-id-type="pmid">17353679</pub-id></mixed-citation></ref><ref id="ref14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silasi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Cardenas</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Kwon</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Racicot</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Aldo</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Mor</surname><given-names>G</given-names></name></person-group>
<article-title>Viral infec-tions during pregnancy</article-title>. <source>Am J Reprod Immunol</source>. <year>2015</year>;<volume>73</volume>(<issue>3</issue>):<fpage>199</fpage>-<lpage>213</lpage>. DOI: <pub-id pub-id-type="doi">10.1111/aji.12355</pub-id>.<pub-id pub-id-type="pmid">25582523</pub-id></mixed-citation></ref><ref id="ref15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schwartz</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Graham</surname><given-names>AL</given-names></name></person-group>
<article-title>Potential maternal and infant outcomes from Coronavirus 2019-nCoV 352 (SARS-CoV-2) infecting preg-nant women: Lessons from SARS, MERS, and other human corona-virus 353 infections</article-title>. <source>Viruses</source>. <year>2020</year>;<volume>12</volume>(<issue>2</issue>). DOI: <pub-id pub-id-type="doi">10.3390/v12020194</pub-id>.</mixed-citation></ref><ref id="ref16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lam</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>SF</given-names></name>, <name name-style="western"><surname>Leung</surname><given-names>TN</given-names></name>, <name name-style="western"><surname>Chow</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>WC</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>TY</given-names></name>, <etal>et al</etal></person-group>
<article-title>A case-controlled study comparing clinical course and outcomes of pregnant and non-pregnant women with severe acute respi-ratory syndrome</article-title>. <source>BJOG</source>. <year>2004</year>;<volume>111</volume>(<issue>8</issue>):<fpage>771</fpage>-<lpage>4</lpage>. DOI: <pub-id pub-id-type="doi">10.1111/j.1471-0528.2004.00199.x</pub-id>.<pub-id pub-id-type="pmid">15270922</pub-id></mixed-citation></ref><ref id="ref17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wong</surname><given-names>SF</given-names></name>, <name name-style="western"><surname>Chow</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Leung</surname><given-names>TN</given-names></name>, <name name-style="western"><surname>Ng</surname><given-names>WF</given-names></name>, <name name-style="western"><surname>Ng</surname><given-names>TK</given-names></name>, <name name-style="western"><surname>Shek</surname><given-names>CC</given-names></name>, <etal>et al</etal></person-group>
<article-title>Preg-nancy and perinatal outcomes of women with severe acute res-piratory syndrome</article-title>. <source>Am J Obstet Gynecol</source>. <year>2004</year>;<volume>191</volume>(<issue>1</issue>):<fpage>292</fpage>-<lpage>7</lpage>. DOI: <pub-id pub-id-type="doi">10.1016/j.ajog.2003.11.019</pub-id>.<pub-id pub-id-type="pmid">15295381</pub-id></mixed-citation></ref><ref id="ref18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shek</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Ng</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Fung</surname><given-names>GP</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>FW</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>PK</given-names></name>, <name name-style="western"><surname>Peiris</surname><given-names>MJ</given-names></name>, <etal>et al</etal></person-group>
<article-title>In-fants born to mothers with severe acute respiratory syndrome</article-title>. <source>Pe-diatrics</source>. <year>2003</year>;<volume>112</volume>(<issue>4</issue>):<fpage>e254</fpage> DOI:<pub-id pub-id-type="doi">10.1542/peds.112.4.e254</pub-id>.</mixed-citation></ref><ref id="ref19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wong</surname><given-names>SF</given-names></name>, <name name-style="western"><surname>Chow</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>de Swiet</surname><given-names>M</given-names></name></person-group>
<article-title>Severe Acute Respiratory Syndro-me and pregnancy</article-title>. <source>BJOG</source>. <year>2003</year>;<volume>110</volume>(<issue>7</issue>):<fpage>641</fpage>-<lpage>2</lpage>. DOI:<pub-id pub-id-type="doi">10.1046/j.1471-0528.2003.03008.x</pub-id>.<pub-id pub-id-type="pmid">12842052</pub-id></mixed-citation></ref><ref id="ref20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Payne</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Iblan</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Alqasrawi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Al Nsour</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Rha</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Tohme</surname><given-names>RA</given-names></name>, <etal>et al</etal></person-group>
<article-title>Stillbirth during infection with Middle East respiratory syndrome coro-navirus</article-title>. <source>J Infect Dis</source>. <year>2014</year>;<volume>209</volume>(<issue>12</issue>):<fpage>1870</fpage>-<lpage>2</lpage>. DOI:<pub-id pub-id-type="doi">10.1093/infdis/jiu068</pub-id>.<pub-id pub-id-type="pmid">24474813</pub-id></mixed-citation></ref><ref id="ref21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Assiri</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Abedi</surname><given-names>GR</given-names></name>, <name name-style="western"><surname>Al Masri</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bin Saeed</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gerber</surname><given-names>SI</given-names></name>, <name name-style="western"><surname>Watson</surname><given-names>JT</given-names></name></person-group>
<article-title>Middle East Respiratory Syndrome Coronavirus Infection During Pregnancy: A Report of 5 Cases From Saudi Arabia</article-title>. <source>Clin Infect Dis</source>. <year>2016</year>;<volume>63</volume>(<issue>7</issue>):<fpage>951</fpage>-<lpage>3</lpage>. DOI:<pub-id pub-id-type="doi">10.1093/cid/ciw412</pub-id>.<pub-id pub-id-type="pmid">27358348</pub-id></mixed-citation></ref><ref id="ref22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Munn</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Peters</surname><given-names>MDJ</given-names></name>, <name name-style="western"><surname>Stern</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Tufanaru</surname><given-names>C</given-names></name>, <name name-style="western"><surname>McArthur</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Aromata-ris</surname><given-names>E</given-names></name></person-group>
<article-title>Systematic review or scoping review?</article-title>
<source>Guidance for authors when choosing between a systematic or scoping review ap-proach</source>. BMC Medical Research Methodology. 19 de noviembre de 2018;18(1):143. DOI:<pub-id pub-id-type="doi">10.1186/s12874-018-0611-x</pub-id></mixed-citation></ref><ref id="ref23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murad</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Sultan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Haffar</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bazerbachi</surname><given-names>F</given-names></name></person-group>
<article-title>Methodological quality and synthesis of case series and case reports</article-title>. <source>BMJ Evid Based Med</source>. <year>2018</year>;<volume>23</volume>(<issue>2</issue>):<fpage>60</fpage>-<lpage>3</lpage>. DOI: <pub-id pub-id-type="doi">10.1136/bmjebm-2017-110853</pub-id>.</mixed-citation></ref><ref id="ref24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moher</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Liberati</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tetzlaff</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Altman</surname><given-names>DG</given-names></name>; <collab>PRISMA Group</collab></person-group>
<article-title>Prefe-rred reporting items for systematic reviews and meta-analyses: the PRISMA</article-title>. <source>J Clin Epidemiol</source>. <year>2009</year>;<volume>62</volume>(<issue>10</issue>):<fpage>1006</fpage>-<lpage>12</lpage>. DOI:<pub-id pub-id-type="doi">10.1016/j.jclinepi.2009.06.005</pub-id>.<pub-id pub-id-type="pmid">19631508</pub-id></mixed-citation></ref><ref id="ref25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Urr&#x000fa;tia</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Bonfill</surname><given-names>X</given-names></name></person-group>
<article-title>Declaraci&#x000f3;n PRISMA: una propuesta para mejo-rar la publicaci&#x000f3;n de revisiones sistem&#x000e1;ticas y metaan&#x000e1;lisis</article-title>. <source>Med Clin (Barc)</source>. <year>2010</year>;<volume>135</volume>(<issue>11</issue>):<fpage>507</fpage>&#x02013;<lpage>511</lpage>. DOI:<pub-id pub-id-type="doi">10.1016/j.medcli.2010.01.015</pub-id>.<pub-id pub-id-type="pmid">20206945</pub-id></mixed-citation></ref><ref id="ref26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Fang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Peng</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>G</given-names></name>, <etal>et al</etal></person-group>
<article-title>Cli-nical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia</article-title>. <source>Transl Pediatr</source>. <year>2020</year>;<volume>9</volume>(<issue>1</issue>):<fpage>51</fpage>-<lpage>60</lpage>. DOI:<pub-id pub-id-type="doi">10.21037/tp.2020.02.06</pub-id>.<pub-id pub-id-type="pmid">32154135</pub-id></mixed-citation></ref><ref id="ref27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Liao</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Cao</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Shao</surname><given-names>Y</given-names></name></person-group>
<article-title>Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia</article-title>. <source>J Med Virol</source>. 2020 DOI:<pub-id pub-id-type="doi">10.1002/jmv.25789</pub-id>.</mixed-citation></ref><ref id="ref28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zambrano</surname><given-names>LI</given-names></name>, <name name-style="western"><surname>Fuentes-Barahona</surname><given-names>IC</given-names></name>, <name name-style="western"><surname>Bejarano-Torres</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Bustillo</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Gonzales</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Vallecillo-Chinchilla</surname><given-names>G</given-names></name>, <etal>et al</etal></person-group>
<article-title>A pregnant woman with COVID-19 in Central America</article-title>. <source>Travel Med Infect Dis</source>. <year>2020</year> DOI:<pub-id pub-id-type="doi">10.1016/j.tmaid.2020.101639</pub-id>.</mixed-citation></ref><ref id="ref29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>Y</given-names></name></person-group>
<article-title>Clinical manifestations and outco-me of SARS-CoV-2 infection during pregnancy</article-title>. <source>J Infect</source>. <year>2020</year> DOI:<pub-id pub-id-type="doi">10.1016/j.jinf.2020.02.028</pub-id>.</mixed-citation></ref><ref id="ref30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name>, <etal>et al</etal></person-group>
<article-title>Clinical cha-racteristics and intrauterine vertical transmission potential of CO-VID-19 infection in nine pregnant women: a retrospective review of medical records</article-title>. <source>Lancet</source>. <year>2020</year>;<volume>395</volume>(<issue>10226</issue>):<fpage>809</fpage>-<lpage>15</lpage>. DOI:<pub-id pub-id-type="doi">10.1016/S0140-6736(20)30360-3</pub-id>.<pub-id pub-id-type="pmid">32151335</pub-id></mixed-citation></ref><ref id="ref31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>L</given-names></name>, <etal>et al</etal></person-group>
<article-title>Pregnancy and Pe-rinatal Outcomes of Women With Coronavirus Disease (COVID-19) Pneumonia: A Preliminary Analysis</article-title>. <source>AJR Am J Roentgenol</source>. 2020 DOI:<pub-id pub-id-type="doi">10.2214/AJR.20.23072</pub-id>.</mixed-citation></ref><ref id="ref32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>X</given-names></name></person-group>
<article-title>A case of 2019 Novel Coronavirus in a pregnant woman with preterm delivery</article-title>. <source>Clin Infect Dis</source>.<year>2020</year> DOI:<pub-id pub-id-type="doi">10.1093/cid/ciaa200</pub-id>.</mixed-citation></ref><ref id="ref33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>BH</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>XC</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>J</given-names></name>, <etal>et al</etal></person-group>
<article-title>[Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei Province]</article-title>. <source>Zhonghua Fu Chan Ke Za Zhi</source>.<year>2020</year> DOI:<pub-id pub-id-type="doi">10.3760/cma.j.cn112141-20200218-00111</pub-id>.</mixed-citation></ref><ref id="ref34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Xiong</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>X</given-names></name>, <etal>et al</etal></person-group>
<article-title>Clinical featu-res and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study</article-title>. <source>Lancet Infect Dis</source>. <year>2020</year> DOI:<pub-id pub-id-type="doi">10.1016/S1473-3099(20)30176-6</pub-id>.</mixed-citation></ref><ref id="ref35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jeong</surname><given-names>SY</given-names></name>, <name name-style="western"><surname>Sung</surname><given-names>SI</given-names></name>, <name name-style="western"><surname>Sung</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Ahn</surname><given-names>SY</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>ES</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>YS</given-names></name>, <etal>et al</etal></person-group>
<article-title>MERS-CoV Infection in a Pregnant Woman in Korea</article-title>. <source>J Korean Med Sci</source>. <year>2017</year>;<volume>32</volume>(<issue>10</issue>):<fpage>1717</fpage>-<lpage>20</lpage>. DOI:<pub-id pub-id-type="doi">10.3346/jkms.2017.32.10.1717</pub-id>.<pub-id pub-id-type="pmid">28875620</pub-id></mixed-citation></ref><ref id="ref36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Robertson</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Lowther</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Birch</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Sorhage</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Stockman</surname><given-names>L</given-names></name>, <etal>et al</etal></person-group>
<article-title>SARS and pregnancy: a case report</article-title>. <source>Emerg Infect Dis</source>. <year>2004</year>;<volume>10</volume>(<issue>2</issue>):<fpage>345</fpage>-<lpage>8</lpage>. DOI:<pub-id pub-id-type="doi">10.3201/eid1002.030736</pub-id>.<pub-id pub-id-type="pmid">15030710</pub-id></mixed-citation></ref><ref id="ref37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>HR</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>DH</given-names></name>, <name name-style="western"><surname>Sung</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name></person-group>
<article-title>Emergency cesarean section in an epidemic of the middle east respiratory syndrome: a case report</article-title>. <source>Korean J Anesthesiol</source>. <year>2016</year>;<volume>69</volume>(<issue>3</issue>):<fpage>287</fpage>-<lpage>91</lpage>. DOI:<pub-id pub-id-type="doi">10.4097/kjae.2016.69.3.287</pub-id>.<pub-id pub-id-type="pmid">27274377</pub-id></mixed-citation></ref><ref id="ref38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stockman</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Lowther</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Coy</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Saw</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Parashar</surname><given-names>UD</given-names></name></person-group>
<article-title>SARS during pregnancy, United States</article-title>. <source>Emerg Infect Dis</source>. <year>2004</year>;<volume>10</volume>(<issue>9</issue>):<fpage>1689</fpage>-<lpage>90</lpage>. DOI:<pub-id pub-id-type="doi">10.3201/eid1009.040244</pub-id>.<pub-id pub-id-type="pmid">15503406</pub-id></mixed-citation></ref><ref id="ref39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alserehi</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wali</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Alshukairi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Alraddadi</surname><given-names>B</given-names></name></person-group>
<article-title>Impact of Middle East Respiratory Syndrome coronavirus (MERS-CoV) on pregnancy and perinatal outcome</article-title>. <source>BMC Infect Dis</source>. <year>2016</year>; <volume>16</volume>:<fpage>105</fpage> DOI:<pub-id pub-id-type="doi">10.1186/s12879-016-1437-y</pub-id>.<pub-id pub-id-type="pmid">26936356</pub-id></mixed-citation></ref><ref id="ref40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>WJ</given-names></name>, <name name-style="western"><surname>Bi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>GF</given-names></name></person-group>
<article-title>On the Centenary of the Spanish Flu: Being Prepared for the Next Pandemic</article-title>. <source>Virol Sin</source>. <year>2018</year>;<volume>33</volume>(<issue>6</issue>):<fpage>463</fpage>-<lpage>6</lpage>. DOI:<pub-id pub-id-type="doi">10.1007/s12250-018-0079-1</pub-id>.<pub-id pub-id-type="pmid">30570715</pub-id></mixed-citation></ref><ref id="ref41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>LL</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Kwak-Kim</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Mor</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Liao</surname><given-names>AH</given-names></name></person-group>
<article-title>Why are pregnant women susceptible to COVID-19?</article-title>
<source>An immunological viewpoint</source>. J Reprod Immunol. <year>2020</year> DOI:<pub-id pub-id-type="doi">10.1016/j.jri.2020.103122</pub-id>.</mixed-citation></ref><ref id="ref42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sutton</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Fuchs</surname><given-names>K</given-names></name>, <name name-style="western"><surname>D&#x02019;Alton</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Goffman</surname><given-names>D</given-names></name></person-group>
<article-title>Universal Screening for SARS-CoV-2 in Women Admitted for Delivery</article-title>. <source>N Engl J Med</source>. <year>2020</year> DOI:<pub-id pub-id-type="doi">10.1056/NEJMc2009316</pub-id>.</mixed-citation></ref><ref id="ref43"><label>43</label><mixed-citation publication-type="web"><article-title>Ministerio de Sanidad, Consumo y Bienestar Social Profesionales Documentos t&#x000e9;cnicos para profesionales Manejo de la mujer embarazada y el reci&#x000e9;n nacido con COVID-19 [Internet]</article-title>. [consultado el 17 de marzo de 2020]. Disponible en: <ext-link ext-link-type="uri" xlink:href="https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Documento_manejo_embarazo_recien_nacido.pdf">https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Documento_manejo_embarazo_recien_nacido.pdf</ext-link>.</mixed-citation></ref><ref id="ref44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Breslin</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Baptiste</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Fuchs</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Goffman</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Gyamfi-Ban-nerman</surname><given-names>C</given-names></name>, <etal>et al</etal></person-group>
<article-title>COVID-19 in pregnancy: early lessons</article-title>. <source>Am J Obstet Gynecol MFM</source>. <year>2020</year> DOI:<pub-id pub-id-type="doi">10.1016/j.ajogmf.2020.100118</pub-id>.</mixed-citation></ref><ref id="ref45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alfaraj</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Al-Tawfiq</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Memish</surname><given-names>ZA</given-names></name></person-group>
<article-title>Middle East Respiratory Syn-drome Coronavirus (MERS-CoV) infection during pregnancy: Re-port of two cases &#x00026; review of the literature</article-title>. <source>J Microbiol Immunol Infect</source>. <year>2019</year>;<volume>52</volume>(<issue>3</issue>):<fpage>501</fpage>-<lpage>3</lpage> DOI:<pub-id pub-id-type="doi">10.1016/j.jmii.2018.04.005</pub-id><pub-id pub-id-type="pmid">29907538</pub-id></mixed-citation></ref><ref id="ref46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nuzum</surname><given-names>JW</given-names></name></person-group> (<year>1918</year>). <article-title>Pandemic influenza and pneumonia in a large civilian hospital</article-title>. <source>JAMA</source>. <year>1918</year>;<volume>71</volume>(<issue>19</issue>):<fpage>1562</fpage>-<lpage>5</lpage>. PMid:.<?supplied-pmid 12100?><pub-id pub-id-type="pmid">12100</pub-id></mixed-citation></ref><ref id="ref47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Della Gatta</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Rizzo</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Pilu</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Simonazzi</surname><given-names>G</given-names></name></person-group>
<article-title>COVID19 du-ring pregnancy:a systematic review of reported cases</article-title>., <source>Ameri-can Journal of Obstetrics and Gynecology</source>. <year>2020</year> DOI:<pub-id pub-id-type="doi">10.1016/j.ajog.2020.04.013</pub-id>.</mixed-citation></ref><ref id="ref48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kimberlin</surname><given-names>DW</given-names></name>, <name name-style="western"><surname>Stagno</surname><given-names>S</given-names></name></person-group>
<article-title>Can SARS-CoV-2 Infection Be Acqui-red In Utero?</article-title><source>: More Definitive Evidence Is Needed</source>.JAMA. <year>2020</year> DOI:<pub-id pub-id-type="doi">10.1001/jama.2020.4868</pub-id>.</mixed-citation></ref><ref id="ref49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chandrasekharan</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Vento</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Trevisanuto</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Partridge</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Un-derwood</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Wiedeman</surname><given-names>J</given-names></name>, <etal>et al</etal></person-group>
<article-title>Neonatal Resuscitation and Postresuscitation Care of Infants Born to Mothers with Suspec-ted or Confirmed SARS-CoV-2 Infection</article-title>. <source>Am J Perinatol</source>. <year>2020</year> DOI:<pub-id pub-id-type="doi">10.1055/s-0040-1709688</pub-id>.</mixed-citation></ref><ref id="ref50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fox</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Marino</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Amanat</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Krammer</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Hahn-Holbrook</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zolla-Pazner</surname><given-names>S</given-names></name>, <etal>et al</etal></person-group>
<article-title>Evidence of a significant secretory-IgA-dominant SARS-CoV-2 immune response in human milk following recovery from COVID-19</article-title>. <source>medRxiv2020</source>. DOI:<pub-id pub-id-type="doi">10.1101/2020.05.04.20089995</pub-id></mixed-citation></ref><ref id="ref51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tapia</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Sow</surname><given-names>SO</given-names></name>, <name name-style="western"><surname>Tamboura B,T&#x000e9;guet&#x000e9;</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Pasetti</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Kodio</surname><given-names>M</given-names></name>, <etal>et al</etal></person-group>
<article-title>Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospec-tive, active-controlled, observer-blind, randomised phase 4 trial</article-title>. <source>Lancet Infect Dis</source>. <year>2016</year>;<volume>16</volume>(<issue>9</issue>):<fpage>1026</fpage>&#x02013;<lpage>1035</lpage>. DOI:<pub-id pub-id-type="doi">10.1016/S1473-3099(16)30054-8</pub-id>.<pub-id pub-id-type="pmid">27261067</pub-id></mixed-citation></ref><ref id="ref52"><label>52</label><mixed-citation publication-type="web"><collab>CDC</collab>. <article-title>Interim Guidance on Breastfeeding for a Mother Confirmed or Under Investigation For COVID-19 [Internet]</article-title> [Consultado el 13 de abril de 2020]. Disponible en: <ext-link ext-link-type="uri" xlink:href="http://www.elactancia.org/media/papers/Interim_Guidance_on_Breastfeeding_for_a_Mother_CO-VID-19-CDC-2020.pdf">http://www.elactancia.org/media/papers/Interim_Guidance_on_Breastfeeding_for_a_Mother_CO-VID-19-CDC-2020.pdf</ext-link></mixed-citation></ref><ref id="ref53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmid</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Fontijn</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ochsenbein-K&#x000f6;lble</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Berger</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bassler</surname><given-names>D</given-names></name></person-group>
<article-title>COVID-19 in pregnant women</article-title>. <source>Lancet Infect Dis</source>. <year>2020</year> DOI:<pub-id pub-id-type="doi">10.1016/S1473-3099(20)30175-4</pub-id></mixed-citation></ref><ref id="ref54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zou</surname><given-names>L</given-names></name>, <etal>et al</etal></person-group>
<article-title>Clinical Charac-teristics of Pregnant Women with Covid-19 in Wuhan, China</article-title>. <source>N Eng J Med</source>. <year>2020</year> DOI:<pub-id pub-id-type="doi">10.1056/NEJMc2009226</pub-id>.</mixed-citation></ref><ref id="ref55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Seo</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Warty</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Payne</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Salih</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Chin</surname><given-names>KL</given-names></name>, <etal>et al</etal></person-group>
<article-title>Mater-nal and neonatal outcomes associated with COVID-19 infection: A systematic review</article-title>. <source>PLoS One</source>. <year>2020</year>;<volume>15</volume>(<issue>6</issue>):<fpage>e0234187</fpage> DOI: <pub-id pub-id-type="doi">10.1371/journal.pone.0234187</pub-id>.<pub-id pub-id-type="pmid">32497090</pub-id></mixed-citation></ref><ref id="ref56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elshafeey</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Magdi</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Hindi</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Elshebiny</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Farrag</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Mahdy</surname><given-names>S</given-names></name>, <etal>et al</etal></person-group>
<article-title>A systematic scoping review of COVID-19 during pregnancy and childbirth</article-title>. <source>Int J Gynaecol Obstet</source>. <year>2020</year>;<volume>150</volume>(<issue>1</issue>):<fpage>47</fpage>-<lpage>52</lpage>. DOI: <pub-id pub-id-type="doi">10.1002/ijgo.13182</pub-id>.<pub-id pub-id-type="pmid">32330287</pub-id></mixed-citation></ref><ref id="ref57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Di Mascio</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Khalil</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Saccone</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Rizzo</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Buca</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Liberati</surname><given-names>M</given-names></name>, <etal>et al</etal></person-group>
<article-title>Outcome of Coronavirus spectrum infections (SARS, MERS, COVID 1-19) during pregnancy: a systematic review and meta-analysis</article-title>. <source>Am J Obstet Gynecol MFM</source>. <year>2020</year>;<volume>2</volume>(<issue>2</issue>):<fpage>100107</fpage> DOI: <pub-id pub-id-type="doi">10.1016/j.ajog-mf.2020.100107</pub-id>.<pub-id pub-id-type="pmid">32292902</pub-id></mixed-citation></ref><ref id="ref58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caparros-Gonzalez</surname><given-names>RA</given-names></name></person-group>
<article-title>Consecuencias maternas y neonatales de la infecci&#x000f3;n por coronavirus COVID-19 durante el embarazo: una scoping review</article-title>. <source>Rev Esp Salud Publica</source>. <year>2020</year>;<volume>94</volume>:<fpage>e202004033</fpage>.<pub-id pub-id-type="pmid">32382001</pub-id></mixed-citation></ref></ref-list></back></article>